IDEXX Laboratories Stock Jumps on Testing Products Demand, Higher Prices
- Shares of IDEXX Laboratories (IDXX) surged 10% to lead S&P 500 gainers Monday after the provider of veterinary healthcare products and services reported better-than-anticipated results on demand for its animal testing products and higher prices.
- 02/03/2025
|
Idexx (IDXX) Reports Q4 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 02/03/2025
|
Idexx: Q4 EPS, Revenue Beat Forecast
- Veterinary diagnostics specialist Idexx Laboratories (IDXX -0.46%) reported fourth-quarter earnings on Monday, Feb. 3, that topped analysts' consensus top- and bottom-line estimates. Revenue for the quarter came in at $954 million against the expected $935 million.
- 02/03/2025
|
Idexx Laboratories (IDXX) Q4 Earnings and Revenues Beat Estimates
- Idexx Laboratories (IDXX) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.40 per share. This compares to earnings of $2.32 per share a year ago.
- 02/03/2025
|
Animal diagnostics maker IDEXX beats quarterly estimates despite low vet visits
- IDEXX Laboratories beat Wall Street estimates for fourth-quarter revenue and profit on Monday, helped by strong demand for its veterinary diagnostic services despite persistent weakness in visits to the vet clinic.
- 02/03/2025
|
IDEXX Laboratories Announces Fourth Quarter and Full Year 2024 Results
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. “IDEXX had a solid finish to 2024, supported by continued high levels of execution by IDEXX teams globally,” said Jay Mazelsky, President and Chief Executive Officer. "The Company is on the front end of a new wave of major innovation. In Q4, we began shipping the IDEXX inVue Dx™ Cellular Analyzer, our transformational sli.
- 02/03/2025
|
IDXX Gears Up for Q4 Earnings: What to Expect From the Stock?
- IDEXX Laboratories' fourth-quarter 2024 performance is expected to have benefited from a strong execution against strategic priorities.
- 01/27/2025
|
IDXX Stock Set to Benefit From IDEXX Cancer Dx Diagnostic Panel Launch
- IDEXX launches new cancer Dx Panel with early detection test for canine lymphoma.
- 01/24/2025
|
IDEXX Laboratories to Release 2024 Fourth Quarter and Full Year Financial Results
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 fourth quarter and full year financial results for Monday, February 3, 2025, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q4 2024 Earnings Snapshot through a link on.
- 01/16/2025
|
IDEXX Stock Suffers Due to Macroeconomic Issues and FX Woes
- With sustained inflationary pressure, IDEXX may struggle to keep its cost of revenues and operating expenses in check.
- 01/15/2025
|
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term
- Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
- 12/26/2024
|
SR Inc Announces 2024 SBER Awards: Top Honors Go to Synopsys, Nell Triplett of Juniper Networks, and IDEXX
- Sustainability Roundtable Inc. announced Synopsys, IDEXX, and Juniper Networks as winners of the 2024 SBER Awards for standout leadership in sustainability
- 12/19/2024
|
A Once-in-a-Decade Opportunity: 2 Magnificent S&P 500 Stocks Down 37% and 28% to Buy Before 2025
- One of my favorite ways to add money to my portfolio is to invest in proven compounders with track records of delivering market-beating results after short-term pullbacks. This idea is especially true when the stocks in question are trading at what could prove to be once-in-a-decade opportunities.
- 12/13/2024
|
Global Expansion to Support IDEXX Stock Despite Macroeconomic Issues
- IDEXX focuses on growing its global commercial capability to sustain strong CAG Diagnostics recurring revenue growth.
- 12/11/2024
|
IDEXX Laboratories Announces Increase in Share Repurchase Program Authorization
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that the Company's Board of Directors authorized an increase in its ongoing share repurchase program, authorizing the repurchase of up to five million additional shares of the Company's common stock. Repurchases may be made at management's discretion from time to time in the open market (including through Rule 10b5-1 plans) or in negotiated transactions. Thes.
- 12/09/2024
|
Should You Hold IDEXX Stock in Your Portfolio for Now?
- IDEXX's robust strength in the CAG Diagnostics business and strong global performance are highly promising.
- 11/22/2024
|
IDEXX Announces CFO Transition
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon has decided to retire from IDEXX effective June 1, 2025. Andrew Emerson, currently Senior Vice President, Corporate and Companion Animal Group (“CAG”) Finance, will succeed Mr. McKeon as IDEXX's Executive Vice President, Chief Financial Officer and Treasurer, effective March 1, 2025. Mr. McKeon will serve as EVP and Special Advisor to the Co.
- 11/21/2024
|
IDEXX Laboratories Q3: Weak End-Market Demand Continues
- I reiterate a 'Sell' rating on IDEXX due to weak U.S. clinical visits and demand, with a one-year price target of $400 per share. IDEXX's Q3 results showed a 2.1% decline in same-store clinical visits and missed market expectations, leading to lowered revenue growth guidance for FY24. Despite strong recurring revenue growth and high retention rates, ongoing macroeconomic challenges and high-interest rates are expected to impact IDEXX's business growth.
- 11/10/2024
|
Is It Time to Buy October's Worst-Performing Nasdaq Stocks?
- Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today.
- 11/06/2024
|
A Once-in-a-Decade Opportunity: 1 Super S&P 500 Stock Down 40% to Buy After Its Recent Pullback
- Trading at its most reasonable valuation since 2016, this pet healthcare diagnostics leader could be a once-in-a-decade opportunity today.
- 11/05/2024
|
IDEXX Laboratories, Inc. (IDXX) Q3 2024 Earnings Call Transcript
- IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - President and CEO Conference Call Participants Michael Ryskin - Bank of America Jonathan Block - Stifel Erin Wright - Morgan Stanley Brandon Vasquez - William Blair David Westenberg - Piper Sandler Operator Good morning, and welcome to the IDEXX Laboratories Third Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded.
- 10/31/2024
|
CORRECTING and REPLACING IDEXX Laboratories Announces Third Quarter Results
- WESTBROOK, Maine--(BUSINESS WIRE)--In the 2024 Growth and Financial Performance Outlook section, second paragraph, second sentence should read: At midpoint, projected full year comparable operating profit margin expansion of 30 - 60 basis points includes a ~40 basis point negative growth impact from lapping a customer contract resolution payment in the first quarter of 2023. (instead of: At midpoint, projected full year comparable operating profit margin expansion of 70 - 100 basis points inclu.
- 10/31/2024
|
Idexx Laboratories Adjusts Guidance As Q3 Revenue Growth Slows, Analyst Notes Fewer Veterinary Visits, Looks Towards Long-Term Growth
- Idexx Laboratories Inc IDXX reported third-quarter adjusted EPS of $2.79, up 12% year-over-year, beating the consensus of $2.68.
- 10/31/2024
|
IDXX Q3 Earnings Top, '24 Sales View Down, Stock Dips in Premarket
- IDXX's Q3 revenues benefit from strong growth in its CAG and Water segments.
- 10/31/2024
|
Idexx (IDXX) Reports Q3 Earnings: What Key Metrics Have to Say
- Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 10/31/2024
|
Idexx Laboratories (IDXX) Q3 Earnings Surpass Estimates
- Idexx Laboratories (IDXX) came out with quarterly earnings of $2.80 per share, beating the Zacks Consensus Estimate of $2.69 per share. This compares to earnings of $2.53 per share a year ago.
- 10/31/2024
|
IDEXX laboratories cuts annual revenue forecast for third time as pet clinic visits slow
- IDEXX Laboratories trimmed its annual revenue forecast for the third time on Thursday, as the animal health diagnostic equipment maker sees fewer visits to veterinary clinics from pet owners.
- 10/31/2024
|
IDEXX Laboratories Announces Third Quarter Results
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company reports revenues of $976 million for the third quarter of 2024, an increase of 7% as reported and 6% organic, driven by Companion Animal Group ("CAG") growth of 7% as reported and 6% organic, and Water revenue growth of 13% as reported and organic. CAG Diagnostics recurring revenue growth of 7% as repor.
- 10/31/2024
|
Seeking Clues to Idexx (IDXX) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
- Evaluate the expected performance of Idexx (IDXX) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 10/28/2024
|
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?
- Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/24/2024
|
IDXX Gears Up for Q3 Earnings: What to Expect From the Stock?
- IDEXX Laboratories' third-quarter 2024 performance is expected to have benefited from a strong execution against strategic priorities.
- 10/16/2024
|
IDEXX Laboratories to Release 2024 Third Quarter Financial Results
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 third quarter results for Thursday, October 31, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. EDT on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q3 2024 Earnings Snapshot through a link on the IDEXX website, www.
- 09/30/2024
|
Why Is Idexx (IDXX) Up 0.9% Since Last Earnings Report?
- Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
- 09/05/2024
|
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024 from 11:30 am – 12:05 pm (EDT). A live audio webcast of the presentation will be available through a.
- 08/21/2024
|
IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits
- IDEXX reported lower full-year organic revenue growth due to reduced U.S. clinical visits. Weak consumer sentiment and ongoing staffing challenges may continue to impact clinical visits in the near future. Launch of new menu expansion for Catalyst platform may drive growth in diagnostic business, but the stock remains overvalued.
- 08/11/2024
|
Animal Health Firm Idexx's Robust Business Model Bolsters Position Despite Slower Growth, Says Analyst
- Tuesday, Idexx Laboratories Inc IDXX reported second-quarter adjusted EPS of $3.02, up 15% year-over-year, beating the consensus of $2.88.
- 08/06/2024
|
IDEXX Laboratories, Inc. (IDXX) Q2 2024 Earnings Call Transcript
- IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q2 2024 Earnings Conference Call August 6, 2024 8:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - President and CEO Conference Call Participants Chris Schott - JPMorgan Michael Ryskin - Bank of America Erin Wright - Morgan Stanley Jonathan Block - Stifel David Westenberg - Piper Sandler Operator Good morning, and welcome to the IDEXX Laboratories Second Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded.
- 08/06/2024
|
IDEXX (IDXX) Q2 Earnings Miss Estimates, 2024 View Down
- IDEXX's (IDXX) Q2 earnings miss estimates but revenues meet the same.
- 08/06/2024
|
Idexx (IDXX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 08/06/2024
|
Idexx Laboratories (IDXX) Lags Q2 Earnings Estimates
- Idexx Laboratories (IDXX) came out with quarterly earnings of $2.44 per share, missing the Zacks Consensus Estimate of $2.87 per share. This compares to earnings of $2.67 per share a year ago.
- 08/06/2024
|
IDEXX Laboratories Announces Second Quarter Results
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results. Second Quarter Results The Company reports revenues of $1,004 million for the second quarter of 2024, an increase of 6% as reported and 7% organic, driven by Companion Animal Group ("CAG") growth of 6% as reported and 7% organic, and Water revenue growth of 9% as reported and 10% organic. CAG Diagnostics recurring revenue growth of 6%.
- 08/06/2024
|
The Zacks Analyst Blog Baxter International, Henry Schein and IDEXX Laboratories
- Baxter International, Henry Schein and IDEXX Laboratories are included in this Analyst Blog.
- 08/06/2024
|
The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data
- This marks the last peak week of the Q2 earnings season with 3,908 companies expected to report. Earnings have come in better-than-expected, but tend to be overshadowed by economic data. Outlier earnings this week include: CSX, CAT, and VFC.
- 08/06/2024
|
What's in Store for These 3 MedTech Stocks in Q2 Earnings?
- MedTech companies' quarterly results are likely to be strong on a sequential basis. Let's see how BAX, HSIC and IDXX are placed ahead of their earnings releases.
- 08/05/2024
|
Unlocking Q2 Potential of Idexx (IDXX): Exploring Wall Street Estimates for Key Metrics
- Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Idexx (IDXX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2024.
- 08/01/2024
|
IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will now host its 2024 second quarter conference call and webcast at 9:00 am ET on Tuesday, August 6, 2024, to minimize conflicts with other industry earnings announcements. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q2 2024 Earnings Snapshot through a link on the IDEXX website, www.idexx.com/investors. An archived e.
- 07/30/2024
|
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?
- Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/30/2024
|
IDEXX Releases 2023 Corporate Responsibility Report, Highlighting Progress Against Its Goals
- WESTBROOK, Maine , July 30, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today published its 2023 Corporate Responsibility Report "Enhancing the Health and Well-being of Pets, People, and Livestock for 40 Years" highlighting progress against its corporate responsibility goals. The Care We Advance IDEXX brings clarity to the complex world of veterinary medicine through diagnostic insights and software solutions that support longer, fuller lives for pets and those who care for them.
- 07/30/2024
|
Strong CAG Sales to Aid IDEXX Laboratories' (IDXX) Q2 Earnings
- IDEXX Laboratories' (IDXX) second-quarter 2024 results are likely to reflect the benefits of strong execution against the growth strategy.
- 07/22/2024
|
Looking For Fast Growth In Healthcare? IDEXX Has You Covered
- IDEXX Laboratories is a $41 billion market cap giant in the diagnostics and research industry, with shares falling 13% since February. The company specializes in animal healthcare diagnostics, showing rapid growth and innovation in a high-growth market. Despite a lofty valuation, IDEXX's strong financials, consistent revenue growth, and long-term growth prospects justify a Buy rating.
- 06/28/2024
|
IDEXX Laboratories to Release 2024 Second Quarter Financial Results
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 second quarter results for Tuesday, August 6, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. EDT on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q2 2024 Earnings Snapshot through a link on the IDEXX website, www.i.
- 06/24/2024
|
IDEXX (IDXX) Business Faces Macroeconomic Woes, FX Headwinds
- IDEXX's (IDXX) supply chain operations bear the brunt of geopolitical instability, including the current war in Ukraine.
- 06/21/2024
|
IDEXX (IDXX) Expands Test Menu for the Catalyst Platform
- IDEXX's (IDXX) new Catalyst Pancreatic Lipase Test is likely to support veterinarians globally in diagnosing pancreatitis.
- 06/06/2024
|
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis
- The launch of the Catalyst® Pancreatic Lipase Test demonstrates IDEXX's Technology for Life strategy and will provide veterinarians with quantitative results at the point-of-care in less than 10 minutes WESTBROOK, Maine , June 4, 2024 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, announces the launch of the Catalyst® Pancreatic Lipase Test, a single-slide solution for canine and feline patients suspected of pancreatitis. With the innovative load-and-go workflow of the Catalyst analyzers, the test can run effortlessly alongside chemistry profiles, leading to a faster path to diagnosis and enhanced patient outcomes.
- 06/04/2024
|
Why Is Idexx (IDXX) Up 5% Since Last Earnings Report?
- Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
- 05/31/2024
|
Barking Up the Right Tree: 3 Top Pet Stocks With ‘Pawsitive' Returns
- The modern pet industry is a testament to the amounts that pet owners and animal lovers are willing to spend on their furry companions. In 2023, U.S. consumers alone spent $147 billion in the pet industry.
- 05/25/2024
|
IDEXX (IDXX) Witnesses Rising Expenses, Currency Issues
- IDEXX (IDXX) is being hurt by geopolitical instability, including the current war in Ukraine, which has affected supply chain operations globally.
- 05/20/2024
|
IDEXX (IDXX) Witnesses Rising Expenses, Currency Issues
- IDEXX Laboratories' (IDXX Quick QuoteIDXX - Free Report) business has been suffering due to complex macroeconomic conditions and unfavorable currency movement. The stock carries a Zacks Rank #4 (Sell) currently.Global macroeconomic conditions, including growing geopolitical complexities, supply chain disruptions leading to increases in the unit cost of raw materials, shortages of healthcare staff, fluctuations in foreign currency exchange rates and volatility in capital markets may continue to affect IDEXX’s results of operations. These challenges, along with geopolitical instability, including the current war in Ukraine, have affected IDEXX’s supply chain operations globally. With sustained inflationary pressure in the future, the company may struggle to keep in check its cost of revenues and operating expenses.During the first quarter of 2024, IDEXX saw a significant 31.3% uptick in general and administrative expenses. Further, U.S. clinical visit growth levels in the first quarter were relatively softer than anticipated, which is likely due to the ongoing staffing challenges at veterinary clinics and broader cumulative macroeconomic pressure on U.S. consumers. Further, the majority of IDEXX's consolidated revenues are from product sales in international markets, with approximately 21% of total revenues in 2023 derived from products manufactured or sourced in U.S. dollars and sold internationally in local currencies. Thus, the strengthening of the rate of exchange for the U.S. dollar relative to other currencies had a negative impact on the company’s revenues derived in currencies other than the U.S. dollar and on profits from products manufactured in the United States and sold internationally. In 2023, foreign exchange reduced operating profits by $25 million (operating margin gains by 60 basis points) and EPS by 24 cents per share.During the first quarter of 2024, it had a limited impact on gross margin, operating profit and EPS. IDEXX’s updated 2024 revenue forecast includes a $35 million impact, equivalent to about a 1% decrease, due to the recent appreciation of the U.S. dollar.IDEXX Laboratories, Inc. Price IDEXX Laboratories, Inc. price | IDEXX Laboratories, Inc. QuoteHowever, IDEXX is focused on growing its global commercial capability to sustain strong CAG Diagnostics recurring revenue growth. In late 2023, the company expanded its operations in the United States for the first time in four years, complementing the seven international expansions it has advanced since 2021. Through these strategic investments, the company continues to strengthen its growth prospects by delivering high-touch commercial engagement in the fastest-growing regions while maintaining strong business performance. This expanded global commercial capability is yielding strong results overseas, with notable 12% organic growth in international CAG diagnostic recurring revenues in the first quarter of 2024. Diagnostics has been one of the fastest-growing areas of the veterinary clinic for IDEXX since the determination of a patient's health status and the best treatment path often requires testing. IDEXX largely provides advanced diagnostic capabilities that meet veterinarians’ diverse needs through a variety of modalities, including in-clinic diagnostic solutions and outside reference laboratory services. These diagnostic capabilities generate a mix of recurring and non-recurring revenues.Key PicksSome better-ranked stocks in the broader medical space are Hims & Hers Health (HIMS Quick QuoteHIMS - Free Report) , High Tide (HITI Quick QuoteHITI - Free Report) and Medpace (MEDP Quick QuoteMEDP - Free Report) . Each of them sports a Zacks Rank #1 (Strong Buy) at present. Hims & Hers Heath stock has rallied 53.3% in the past year. Earnings estimates for the company have risen from 10 cents to 18 cents in 2024 and from 23 cents to 32 cents in 2025 in the past 30 days.HIMS’ earnings beat estimates in three of the trailing four quarters and missed in one, delivering an average surprise of 79.2%. In the last reported quarter, it posted an earnings surprise of a staggering 150%.Estimates for High Tide’s 2024 earnings per share have remained unchanged in the past 30 days. Shares of the company have surged 57.9% upward in the past year against the industry’s fall of 0.6%.HITI’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 91.7%. In the last reported quarter, it delivered an earnings surprise of 100%.Estimates for Medpace’s 2024 earnings per share have moved up to $11.29 from $10.53 in the past 30 days. Shares of the company have risen 87.6% in the past year compared with the industry’s 5% growth.MEDP’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 12.8%. In the last reported quarter, it delivered an earnings surprise of 30.6%. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time. This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>
- 05/20/2024
|
IDEXX Laboratories to Present at Stifel Conference and Announces 2024 Investor Day
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Brian McKeon, Executive Vice President and Chief Financial Officer, and Michael Lane, Executive Vice President, General Manager, Reference Laboratories and Information Technology, will participate in a fireside chat at the Stifel Jaws & Paws Conference on Wednesday, May 29, 2024 from 10:55 am – 11:25 am (EDT). A live audio webcast of the presentation.
- 05/14/2024
|
Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI
- Fortune.com recently reported that artificial intelligence (AI) is helping the pet care industry cope with a chronic veterinary shortage. AI use cases could become far more prevalent for pets than humans in the near term due to fewer impediments such as privacy laws.
- 05/01/2024
|
IDEXX (IDXX) Q1 Earnings Surpass Estimates, 2024 View Slashed
- IDEXX (IDXX) delivers better-than-expected earnings in the first quarter of 2024.
- 05/01/2024
|
Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics
- While the top- and bottom-line numbers for Idexx (IDXX) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 05/01/2024
|
Idexx Laboratories (IDXX) Tops Q1 Earnings Estimates
- Idexx Laboratories (IDXX) came out with quarterly earnings of $2.81 per share, beating the Zacks Consensus Estimate of $2.68 per share. This compares to earnings of $2.55 per share a year ago.
- 05/01/2024
|
IDEXX Labs cuts 2024 revenue forecast on lagging vet visits, strong dollar
- IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the animal diagnostic equipment maker expects a hit from a slowdown in veterinary clinic visits by pet owners and a stronger dollar.
- 05/01/2024
|
IDEXX Laboratories Announces First Quarter Results
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results. First Quarter Results The Company reports revenues of $964 million for the first quarter of 2024, an increase of 7% as reported and organic, driven by Companion Animal Group ("CAG") growth of 7% as reported and organic, and Water revenue growth of 11% as reported and organic. Overall IDEXX revenue gains were net of an estimated 0.5% - 1.
- 05/01/2024
|
How to trade Fed news, plus stocks to consider
- The Federal Reserve has entered a two-day meeting that will end with an announcement about its decision regarding interest rates. In the meantime, debate on Wall Street has been raging over how, when, and if the Fed will raise rates.
- 04/30/2024
|
Seeking Clues to Idexx (IDXX) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
- Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Idexx (IDXX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2024.
- 04/26/2024
|
What Lies Ahead of IDEXX Laboratories (IDXX) in Q1 Earnings?
- IDEXX Laboratories' (IDXX) first-quarter 2024 results are likely to reflect the benefits of strong execution against the growth strategy.
- 04/19/2024
|
TMO vs. IDXX: Which Stock Is the Better Value Option?
- Investors looking for stocks in the Medical - Instruments sector might want to consider either Thermo Fisher Scientific (TMO) or Idexx Laboratories (IDXX). But which of these two stocks offers value investors a better bang for their buck right now?
- 04/18/2024
|
New AI Bot Predicts These 7 Stocks Will Mint Millionaires
- You may have heard about GPT-4 Turbo, Gemini, Llama or X's (formerly Twitter) Grok. However, there is a new contender outside of these Big Tech models in town.
- 04/12/2024
|
Idexx Laboratories (IDXX) Beats Stock Market Upswing: What Investors Need to Know
- Idexx Laboratories (IDXX) concluded the recent trading session at $519.81, signifying a +0.99% move from its prior day's close.
- 04/09/2024
|
All You Need to Know About Idexx (IDXX) Rating Upgrade to Buy
- Idexx (IDXX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- 04/09/2024
|
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?
- Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 04/05/2024
|
IDEXX Laboratories to Release 2024 First Quarter Financial Results
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day. Individuals can access a live webcast of the conference call, transcript of prepared remarks, and the Q1 2024 Earnings Snapshot through a link on the IDEXX website, www.idex.
- 04/04/2024
|
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
- The strength of the CAG Diagnostics business buoys optimism for IDEXX (IDXX).
- 04/02/2024
|
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences: Thursday, February 29, 10:50 am – 11:30 am EST – Brian McKeon, Executive Vice President and Chief Financial Officer, and Tina Hunt, PhD, Executive Vice President, Strategy, Sector Development and Global Operations, will participate in a fireside chat at the BofA Securities Animal Health Virtual Summit. Monday, March 4, 11:00 am –.
- 02/20/2024
|
IDEXX (IDXX) Unveils Pet Owner Engagement Software Solution
- IDEXX's (IDXX) Vello software is an intuitive solution designed specifically for practice management software that enables practitioners to interact with pet owners before and after visits.
- 02/16/2024
|
Here's Why You Should Retain IDEXX (IDXX) Stock for Now
- IDEXX Laboratories, Inc. IDXX is likely to grow in the coming quarters, backed by the sustained success of CAG's recurring diagnostic products and services. The company's international business performance is gaining from its expanded global commercial capability.
- 02/15/2024
|
IDEXX's (IDXX) Global Growth Continues, Currency Woes Persist
- A key element of IDEXX's (IDXX) customer engagement strategy is the expansion of its commercial footprint in a disciplined approach.
- 02/08/2024
|
IDEXX Laboratories, Inc. (IDXX) Q4 2023 Earnings Call Transcript
- IDEXX Laboratories, Inc. (IDXX) Q4 2023 Earnings Call Transcript
- 02/05/2024
|
IDEXX (IDXX) Q4 Earnings Surpass Estimates, Margins Fall
- Across testing modalities, IDEXX (IDXX) achieves strong global growth in the fourth quarter.
- 02/05/2024
|
Idexx (IDXX) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
- While the top- and bottom-line numbers for Idexx (IDXX) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- 02/05/2024
|
Idexx Laboratories (IDXX) Q4 Earnings and Revenues Top Estimates
- Idexx Laboratories (IDXX) came out with quarterly earnings of $2.32 per share, beating the Zacks Consensus Estimate of $2.12 per share. This compares to earnings of $2.05 per share a year ago.
- 02/05/2024
|
Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings?
- IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 02/02/2024
|
IQV or IDXX: Which Is the Better Value Stock Right Now?
- Investors interested in stocks from the Medical - Instruments sector have probably already heard of IQVIA Holdings (IQV) and Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks?
- 01/31/2024
|
Unveiling Idexx (IDXX) Q4 Outlook: Wall Street Estimates for Key Metrics
- Evaluate the expected performance of Idexx (IDXX) for the quarter ended December 2023, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
- 01/31/2024
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
- Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
- 01/31/2024
|
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
- Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business.
- 01/31/2024
|
Why Idexx (IDXX) is Poised to Beat Earnings Estimates Again
- Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/30/2024
|
IDEXX Laboratories (IDXX) to Post Q4 Earnings: What's in Store?
- Strength in CAG Diagnostics and Water businesses are likely to have boosted IDEXX Laboratories' (IDXX) revenues in Q4.
- 01/29/2024
|
IDEXX (IDXX) Enhances Fecal Dx Antigen Testing Platform
- IDEXX's (IDXX) Fecal Dx antigen testing detects the most prevalent and clinically relevant intestinal parasites in dogs and cats.
- 01/15/2024
|
3 Purrfect Stocks to Buy for the Booming Pet Care Industry
- The pet care industry went through a massive growth spurt during the pandemic when it seemed everyone had to own a companion pet. This lit a fire under pet care stocks.
- 01/11/2024
|
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
- Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business.
- 12/18/2023
|
ALC or IDXX: Which Is the Better Value Stock Right Now?
- Investors with an interest in Medical - Instruments stocks have likely encountered both Alcon (ALC) and Idexx Laboratories (IDXX). But which of these two stocks presents investors with the better value opportunity right now?
- 11/16/2023
|
IDEXX's (IDXX) Upcoming Launch to Detect Canine Leishmaniosis
- IDEXX (IDXX) expands the SNAP franchise with a comprehensive solution for detecting canine leishmaniosis.
- 11/13/2023
|
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
- Investors continue to be optimistic about IDEXX (IDXX), backed by the strength of the CAG Diagnostics business and momentum in ProCyte One expansion.
- 11/09/2023
|
Compared to Estimates, Idexx (IDXX) Q3 Earnings: A Look at Key Metrics
- Although the revenue and EPS for Idexx (IDXX) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
- 11/01/2023
|
Among the S&P 500, these 20 companies have made the best use of investors' money
- There is no easy way to select individual stocks. Measures of financial quality can highlight companies that are worth a closer look, but a decision to commit money must also take into consideration both recent developments and a look ahead.
- 10/25/2023
|
IDEXX Laboratories (IDXX) to Post Q3 Earnings: What's in Store?
- IDEXX Laboratories' (IDXX) third-quarter 2023 results are expected to reflect an impressive performance of the CAG segment.
- 10/23/2023
|
IART vs. IDXX: Which Stock Is the Better Value Option?
- Investors interested in Medical - Instruments stocks are likely familiar with Integra LifeSciences (IART) and Idexx Laboratories (IDXX). But which of these two stocks offers value investors a better bang for their buck right now?
- 10/13/2023
|
3 Stocks Ready to Rocket on These Global Mega Trends
- Many investors are used to looking for sectors to make bets on. Technology.
- 09/28/2023
|
Here's Why You Should Hold on to IDEXX (IDXX) Stock Right Now
- Investors are optimistic about IDEXX (IDXX) on solid premium instrument placements and upbeat guidance.
- 09/19/2023
|
Which Is A Better Pick – Kimberly-Clark Stock Or IDEXX Laboratories?
- Given its better prospects, we believe that IDEXX Laboratories stock (NASDAQ: IDXX) is a better pick over Kimberly-Clark stock (NYSE: KMB).
- 09/15/2023
|
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
- Investors continue to be optimistic about IDEXX (IDXX) due to the CAG business and the company's execution of its growth strategy.
- 08/18/2023
|
3 Top Healthcare Stocks to Buy for August
- Humana delivered better-than-expected second-quarter earnings. Vertex Pharmaceuticals has three potential blockbuster therapies on the way.
- 08/05/2023
|
Atlantic Equities Downgrades Idexx Laboratories
- Fintel reports that on August 2, 2023, Atlantic Equities downgraded their outlook for Idexx Laboratories (NASDAQ:IDXX) from Overweight to Neutral.
- 08/02/2023
|
IDEXX Laboratories, Inc. (IDXX) Q2 2023 Earnings Call Transcript
- IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q2 2023 Earnings Conference Call August 1, 2023 8:30 AM ET Company Participants Jay Mazelsky - President and Chief Executive Officer Brian McKeon - Chief Financial Officer John Ravis - Vice President, Investor Relations Conference Call Participants Nathan Rich - Goldman Sachs Michael Ryskin - Bank of America Ryan Daniels - William Blair John Block - Stifel David Westenberg - Piper Sandler Operator Good morning, and welcome to the IDEXX Laboratories Second Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.
- 08/01/2023
|
IDEXX (IDXX) Q2 Earnings and Revenues Beat Estimates, View Up
- IDEXX (IDXX) delivers better-than-expected earnings and revenues in the second quarter of 2023, backed by CAG Diagnostics' recurring revenue growth.
- 08/01/2023
|
Idexx (IDXX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
- The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 08/01/2023
|
Idexx Laboratories (IDXX) Q2 Earnings and Revenues Beat Estimates
- Idexx Laboratories (IDXX) came out with quarterly earnings of $2.67 per share, beating the Zacks Consensus Estimate of $2.43 per share. This compares to earnings of $1.56 per share a year ago.
- 08/01/2023
|
IDEXX Laboratories (IDXX) to Post Q2 Earnings: What's in Store?
- IDEXX Laboratories' (IDXX) second-quarter 2023 results are expected to reflect an impressive performance in the CAG segment.
- 07/21/2023
|
Idexx Laboratories (IDXX) is a Top-Ranked Momentum Stock: Should You Buy?
- The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
- 07/14/2023
|
IDEXX: One Of The Best Compounders On The Market
- IDEXX Laboratories, a healthcare supplier specializing in veterinary health diagnostics and research, is a potential high-performing compounder due to its wide-moat business model, anti-cyclical customers, strong pricing power, and high free cash flow conversion. Despite not offering dividends, IDEXX has returned nearly 1,000% over the past decade, and its focus on fast-growing veterinary healthcare and aim to increase its installed base of premium instruments could contribute to further revenue expansion.
- 06/29/2023
|
IDEXX (IDXX) Stock Up 18.4% YTD: Will the Rally Continue?
- The continued solid demand for veterinary services and benefits from strong execution poise IDEXX (IDXX) well for future growth.
- 06/19/2023
|
IDEXX (IDXX) Launches First Veterinary Diagnostic Test
- IDEXX's (IDXX) Cystatin B Test can help veterinary professionals to spot kidney damage before it affects kidney function, which may result in better patient outcomes.
- 06/16/2023
|
3 Nasdaq Stocks That Have Generated 10x Returns in 10 Years
- Investing $10,000 into Apple, Nvidia, or Idexx Laboratories a decade ago would have netted you more than $100,000 today. Both Apple and Nvidia have some exciting next-gen growth opportunities to pursue that could ensure their businesses continue to grow in the years ahead.
- 06/08/2023
|
Here's Why You Should Invest in IDEXX (IDXX) Right Now
- Investors continue to be optimistic about IDEXX (IDXX) on the strength of the Companion Animal Group business.
- 06/06/2023
|
IDEXX Laboratories to Present at Stifel Conference and Announces 2023 Investor Day
- WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Stifel Jaws & Paws Conference on Wednesday, May 31, 2023. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at 1:15 pm (EDT). Individuals can access the live audio webcast of the presentation through a link on the IDEXX website, www.idexx.
- 05/10/2023
|
3 Best Stocks to Buy in May and Hold Forever
- Teladoc looks to transition from a high-flying growth story to a profitable enterprise. Doximity's early profitability and cash generation point to incredible potential ahead.
- 05/10/2023
|
IDEXX (IDXX) Q1 Earnings Beat Estimates, Margins Increase
- Continued solid demand for veterinary services and record global premium instrument placements drive IDEXX's (IDXX) Q1 revenues.
- 05/02/2023
|
IDEXX Laboratories, Inc. (IDXX) Q1 2023 Earnings Call Transcript
- IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q1 2023 Earnings Conference Call May 2, 2023 8:30 AM ET Company Participants Jay Mazelsky - President and Chief Executive Officer Brian McKeon - Executive Vice President, Chief Financial Officer John Ravis - Vice President, Investor Relations Conference Call Participants Nathan Rich - Goldman Sachs Christopher Schott - JPMorgan Jonathan Block - Stifel Michael Ryskin - Bank of America Jack Senft - William Blair Erin Wright - Morgan Stanley David Westenberg - Piper Sandler Operator Good morning, and welcome to the IDEXX Laboratories First Quarter 2023 Earnings Conference Call. As a reminder, today's conference is being recorded.
- 05/02/2023
|
Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics
- The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
- 05/02/2023
|
Idexx Laboratories (IDXX) Q1 Earnings and Revenues Beat Estimates
- Idexx Laboratories (IDXX) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $2.38 per share. This compares to earnings of $2.27 per share a year ago.
- 05/02/2023
|
Why These 2 Vet Med Stocks Are Surging
- Nearly 87 million households -- over two-thirds of the total -- own at least one pet. Spending on pet healthcare could nearly double by 2030 to $112 billion.
- 04/28/2023
|
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?
- Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/25/2023
|
7 ESG Stocks to Buy That Analysts Love
- Stereotypically, the concept of bidding up publicly traded enterprises based on their environmental, social, and governance scores – the so-called ESG stocks – might seem an extremely risky proposition. That's because we have this idea that doing good involves sacrificing capitalistic intent like achieving profitability.
- 04/25/2023
|
3 Pet Stocks That Could Purr in 2023 and Beyond
- Animal-loving investors may be interested in exploring opportunities in the pet industry. While there are altruistic reasons for supporting companies that focus on the well-being of our furry friends, pet stocks have also seen impressive growth over the past decade, which was accelerated by the pandemic.
- 04/24/2023
|
IDEXX Laboratories (IDXX) to Post Q1 Earnings: What's in Store?
- IDEXX Laboratories' (IDXX) first-quarter 2023 results are expected to reflect an impressive performance in the CAG segment despite inflationary impacts.
- 04/21/2023
|
ALC vs. IDXX: Which Stock Is the Better Value Option?
- Investors interested in stocks from the Medical - Instruments sector have probably already heard of Alcon (ALC) and Idexx Laboratories (IDXX). But which of these two stocks offers value investors a better bang for their buck right now?
- 04/12/2023
|
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
- Investors are optimistic about IDEXX's (IDXX) strength in the Companion Animal Group business.
- 04/10/2023
|
Why Is Idexx (IDXX) Down 6.6% Since Last Earnings Report?
- Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
- 03/08/2023
|
TMO or IDXX: Which Is the Better Value Stock Right Now?
- TMO vs. IDXX: Which Stock Is the Better Value Option?
- 03/08/2023
|
Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now
- Investors are optimistic about IDEXX's (IDXX) strong global performance.
- 02/28/2023
|
IDEXX (IDXX) Global Sales, Instrument Placement Robust
- IDEXX (IDXX) continues to demonstrate solid growth globally, primarily aided by a gain in CAG and Water businesses.
- 02/27/2023
|
IDEXX Laboratories: Excellent Business But Extremely Overpriced
- IDEXX Laboratories, Inc. is a U.S. healthcare company, that currently leads the veterinary industry developing diagnostics tools to satisfy veterinarians' everyday needs. IDEXX has delivered solid and consistent results that rival those of Google's, Metas', and Microsoft's out there.
- 02/24/2023
|
3 Medical Instruments Stocks to Buy Amid Improving Industry Trends
- The Zacks Medical - Instruments industry is growing on rising demand for digital health. EW, IDXX and HOLX are set to gain the most.
- 02/23/2023
|
Are Medical Stocks Lagging IDEXX Laboratories (IDXX) This Year?
- Here is how Idexx Laboratories (IDXX) and Aeterna Zentaris (AEZS) have performed compared to their sector so far this year.
- 02/23/2023
|
TMO vs. IDXX: Which Stock Is the Better Value Option?
- TMO vs. IDXX: Which Stock Is the Better Value Option?
- 02/20/2023
|
2 Top Healthcare Stocks to Buy Right Now
- One has a breakout drug, the other a nice-sized moat.
- 02/13/2023
|
2 Top Stocks I'm Buying Hand Over Fist in February
- Despite underwhelming earnings reports, these businesses remain great investments in 2023.
- 02/10/2023
|
IDEXX Laboratories, Inc. (IDXX) Q4 2022 Earnings Call Transcript
- IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q4 2022 Results Conference Call February 6, 2023 8:30 AM ET Company Participants Jay Mazelsky - President and Chief Executive Officer Brian McKeon - Chief Financial Officer John Ravis - Vice President, Investor Relations Conference Call Participants Nathan Rich - Goldman Sachs Chris Schott - JPMorgan Erin Wright - Morgan Stanley Michael Ryskin - Bank of America Jon Block - Stifel Ryan Daniels - William Blair Operator Good morning, and welcome to the IDEXX Laboratories Fourth Quarter 2022 Earnings Conference Call. As a reminder, today's conference is being recorded.
- 02/06/2023
|
IDEXX (IDXX) Q4 Earnings Beat Estimates, Margins Increases
- IDEXX's (IDXX) Q4 revenues are driven by continued benefits from expanding the global premium instrument installed base.
- 02/06/2023
|
Idexx Laboratories (IDXX) Q4 Earnings and Revenues Beat Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 6.77% and 1.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- 02/06/2023
|
SONVY or IDXX: Which Is the Better Value Stock Right Now?
- SONVY vs. IDXX: Which Stock Is the Better Value Option?
- 01/31/2023
|
Top 5 Nasdaq Composite Stocks to Buy Ahead of Q4 Earnings
- Five Nasdaq Composite companies are set to beat earnings estimates. These are: EXPE, IDXX, SNY, TW and SEDG.
- 01/31/2023
|
Nasdaq Off To Its Fastest Start Since 2019 — These Stocks Are Leading The Charge
- The Nasdaq composite is up 6.44% in 2023, its best start to a new year. These are the big Nasdaq winners, including some megacaps.
- 01/23/2023
|
Nasdaq Off To Its Fastest Start Since 2019 — These Stocks Are Leading The Charge
- The Nasdaq composite is up 6.44% in 2023, its best start to a new year. These are the big Nasdaq winners, including some megacaps.
- 01/22/2023
|
Why Idexx (IDXX) Could Beat Earnings Estimates Again
- Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 01/17/2023
|
IDEXX (IDXX) Aided by Global Growth, Solid Instrument Placement
- IDEXX's (IDXX) rapid assay revenue growth is supported by solid volume gains in the United States and benefits from net price increases.
- 01/17/2023
|
5 Stocks Powering Nasdaq ETF to Start 2023
- The rally has been broad-based. And the high beta and high growth sector took charge, with the tech-heavy Nasdaq Composite Index rising 5.1% in the initial two weeks of 2023.
- 01/13/2023
|
VolitionRx announces expansion of availability of Nu.Q Vet Cancer Test availability through IDEXX's reference laboratory network
- VolitionRx Ltd (NYSE-A:VNRX) has announced the availability of its Nu.Q Vet Cancer Test through the IDEXX Laboratories Inc reference laboratory network in the US. The Henderson, Nevada-based multi-national epigenetics company noted that IDEXX is a global leader in pet healthcare innovation and is well-positioned to roll out the IDEXX Nu.Q Canine Cancer Screen worldwide.
- 01/12/2023
|
7 Nasdaq Stocks to Buy and Hold Forever
- After watching the Nasdaq lose roughly a third of its value in 2022, investors might rightly be wary of that particular stock exchange. However, the truth is that there are still plenty of Nasdaq stocks that have created tremendous wealth for long-term investors.
- 01/08/2023
|
IDEXX Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
- WESTBROOK, Maine , Dec. 22, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 5, 2023. Jay Mazelsky, President and Chief Executive Officer will participate in a fireside chat at 1:15 pm ET.
- 12/22/2022
|
The 7 Best Stocks to Buy for 2023
- There are just a couple of weeks left in 2022. I've been tasked with selecting the seven best stocks to buy for 2023.
- 12/14/2022
|
IDEXX (IDXX) CAG Sales Growth Strong, Costs Continue to Rise
- IDEXX's (IDXX) international revenues are primarily aided by gains in CAG and Water businesses.
- 12/14/2022
|
Is There More Room For Growth In IDEXX Laboratories Stock?
- This 137% growth for IDXX stock since late 2018 can primarily be attributed to 1 the company's P/S ratio rising 53% to 11.1x trailing revenues, from 7.3x in 2018, 2.
- 11/15/2022
|
IDEXX (IDXX) Q3 Earnings Beat Estimates, 2022 EPS View Down
- IDEXX's (IDXX) Q3 top-line performance rides on strong CAG Diagnostics recurring revenue growth.
- 11/01/2022
|
IDEXX Laboratories, Inc. (IDXX) Q3 2022 Earnings Call Transcript
- IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q3 2022 Earnings Conference Call November 1, 2022 8:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - CEO Conference Call Participants Chris Schott - JPMorgan Erin Wright - Morgan Stanley Jon Block - Stifel Nathan Rich - Goldman Sachs David Westenberg - Piper Sandler Ryan Daniels - William Blair Elliot Wilbur - Raymond James Operator Good morning, and welcome to the IDEXX Laboratories Third Quarter 2022 Earnings Conference Call. As a reminder, today's conference is being recorded.
- 11/01/2022
|
Why IDEXX Stock Popped Today
- The animal healthcare company beat estimates on the top and bottom lines.
- 11/01/2022
|
Idexx Laboratories (IDXX) Beats Q3 Earnings and Revenue Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 5.39% and 1.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- 11/01/2022
|
A Quality Checkup On IDEXX Laboratories
- IDEXX Laboratories is operating in an industry with good tailwinds. Over the last decade, IDEXX Laboratories returned 22% annually, but future returns will likely be much lower.
- 10/26/2022
|
7 Nasdaq Stocks to Buy and Hold Forever
- The Nasdaq is known for high-flying growth stocks, not necessarily buy-and-hold candidates. Electric vehicles, biotechnology, social networking stocks, cloud software companies and the like.
- 10/13/2022
|
Don't Miss the Turnaround in These 3 Stocks
- I'm on the hunt for stocks to buy that are primed for a turnaround in the final quarter of 2022 and into 2023. But what constitutes a turnaround?
- 10/04/2022
|
Should You Buy IDEXX Laboratories Stock At Around $350?
- IDEXX Laboratories stock (NASDAQ: IDXX) has seen a 48% decline this year, faring far worse than an 18% fall for the broader S&P500 index.
- 09/08/2022
|
5 Pet Care Stocks Gurus Love
- Despite inflationary pressures that are increasing the price of goods across the board, consumers are still pampering their pets when it comes to food.
- 09/02/2022
|
Why Is Idexx (IDXX) Down 14.6% Since Last Earnings Report?
- Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
- 09/01/2022
|
IDEXX (IDXX) Suffers From Macro Headwinds, Cost Constraints
- The strengthening of the rate of exchange for the U.S. dollar relative to other currencies has a negative impact on IDEXX's (IDXX) revenues.
- 08/18/2022
|
IDEXX Laboratories: Outstanding Business, But Valuation Is Key
- IDEXX Laboratories enjoys a dominant market position in the veterinary care ecosystem. It is also establishing itself in adjacencies like livestock and water testing. The company's business has sticky, recurring revenues with strong defensibility during uncertain economic times.
- 08/15/2022
|
IDEXX (IDXX) Q2 Earnings Surpass Estimates, 2022 View Down
- IDEXX's (IDXX) Q2 top-line benefits from strong sales at the CAG and Water businesses.
- 08/02/2022
|
IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2022 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Brian McKeon - Executive Vice President, Chief Financial Officer & Treasurer Jay Mazelsky - President & Chief Executive Officer Conference Call Participants Michael Ryskin - Bank of America Chris Schott - JPMorgan Erin Wright - Morgan Stanley Jon Block - Stifel Elliot Wilbur - Raymond James Ryan Daniels - William Blair Operator Good morning, and welcome to the IDEXX Laboratories Second Quarter 2022 Earnings Conference Call. As a reminder, today's conference is being recorded.
- 08/02/2022
|
Idexx Laboratories (IDXX) Surpasses Q2 Earnings Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 1.30% and 0.43%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- 08/02/2022
|
OCPNY or IDXX: Which Is the Better Value Stock Right Now?
- OCPNY vs. IDXX: Which Stock Is the Better Value Option?
- 07/27/2022
|
The 3 Best Pet Stocks to Buy Now
- Pets are a big part of the family in America and that trend is only growing. Here are some top pet stocks to help you profit from the trend.
- 07/04/2022
|
Why Is Idexx (IDXX) Up 0.3% Since Last Earnings Report?
- Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
- 06/03/2022
|
IDEXX's (IDXX) Soft LPD Sales, Margin Pressure Concern
- Distributor purchasing dynamics have an impact on IDEXX's (IDXX) CAG segment product sales.
- 05/25/2022
|
IDEXX Laboratories: Great Business, But Still Overvalued
- IDEXX Laboratories offers products and services in the animal companion diagnostics and testing space. The company has an outstanding track record regarding deployment of capital and shareholder returns.
- 05/25/2022
|
IDEXX Laboratories to Present at Stifel Conference and Announces 2022 Investor Day
- WESTBROOK, Maine , May 18, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Jaws & Paws Conference on Wednesday, June 1, 2022. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at 1:50 pm (EDT).
- 05/18/2022
|
IDEXX (IDXX) Q1 Earnings Surpass Estimates, Margins Down
- Strong sales at the CAG and Water businesses drove IDEXX's (IDXX) first-quarter 2022 revenues.
- 05/04/2022
|
IDEXX Laboratories, Inc. (IDXX) CEO Jonathan Mazelsky on Q1 2022 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc. (NASDAQ:IDXX ) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Brian McKeon - CFO, EVP & Treasurer Jonathan Mazelsky - President, CEO & Director Conference Call Participants Christopher Schott - JPMorgan Chase & Co Michael Ryskin - Bank of America Merrill Lynch Erin Wright - Morgan Stanley Jonathan Block - Stifel, Nicolaus & Company Nathan Rich - Goldman Sachs Group Balaji Prasad - Barclays Bank Operator Good morning, and welcome to the IDEXX Laboratories First Quarter 2022 Earnings Conference Call. As a reminder, today's conference is being recorded.
- 05/04/2022
|
Idexx Laboratories (IDXX) Q1 Earnings Beat Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 0.89% and 0.57%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
- 05/04/2022
|
Why ESG Investing Doesn't Actually Work
- The practice of investing based on environmental, social and governance (ESG) criteria has become increasingly popular over the years. Last year was a banner year for cash inflows to ESG funds, with these funds reaching a record of approximately $330 billion in collective assets under management according to data from Morningstar.
- 05/03/2022
|
MedTech Stocks' Q1 Earnings Due on May 4: CRL, IDXX & NUVA
- MedTech companies' results are likely to reflect a rebound in the base business. Let's see how CRL, IDXX and NUVA fare this time.
- 05/03/2022
|
Earnings Preview: Idexx Laboratories (IDXX) Q1 Earnings Expected to Decline
- Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/27/2022
|
According To Analysts, These 12 Fast-Rising Stocks Are On The Way Up
- A dozen S&P 500 stocks are up strongly from the market's low this year, including consumer discretionary firms Pool and D.R. Horton plus communications services company Dish Network.
- 04/14/2022
|
Wall Street Thinks This Stock Has 50% Upside
- That prediction might be too conservative.
- 04/14/2022
|
IDEXX (IDXX) CAG Sales Gain Traction, FX Headwind Persists
- IDEXX (IDXX) has been witnessing continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.
- 04/12/2022
|
IHI: A Standout Performer With Equally Strong Future Growth Prospects
- IHI: A Standout Performer With Equally Strong Future Growth Prospects
- 03/05/2022
|
Riding The Stock Waves: Update On The Medical Devices Sector
- Riding The Stock Waves: Update On The Medical Devices Sector
- 02/21/2022
|
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences
- WESTBROOK, Maine, Feb. 17, 2022 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in two upcoming conferences: Thursday, February 24, 9:55 am EST – Tina Hunt, PhD, Executive Vice President and General Manager, Point of Care Diagnostics and Worldwide Operations and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at the BofA Securities Animal Health Summit. Monday, March 7, 11:00 am EST – Jay Mazelsky, President and Chief Executive Officer, will present at the 43rd Annual Raymond James Institutional Investors Conference.
- 02/17/2022
|
Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now
- Robust domestic and international performances by the CAG arm are driving IDEXX's (IDXX) fourth-quarter top line.
- 02/17/2022
|
2 Stocks With COVID Gains Wall Street Shouldn't Erase
- These charts show how some pandemic winners will keep delivering for shareholders.
- 02/09/2022
|
IDEXX: The Robust Stalwart
- A stalwart stock, according to legendary investor Peter Lynch, is a large, stable company that still has attractive growth potential.
- 02/08/2022
|
IDEXX's (IDXX) CAG Diagnostic Sales Gain, Cost Woe Stays
- IDEXX (IDXX) witnesses continued high CAG Diagnostics recurring revenue growth across major regions with solid gains across its key in-clinic platforms.
- 02/08/2022
|
IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q4 2021 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q4 2021 Results - Earnings Call Transcript
- 02/02/2022
|
IDEXX Laboratories And Its Real Value
- IDEXX Laboratories has directly benefitted from the COVID-19 pandemic as diagnostic testing of animals has increased. Share prices and earnings per share have been increasing consistently over the last decade.
- 02/02/2022
|
IDEXX (IDXX) Q4 Earnings Beat Estimates, Gross Margin Up
- Growth in CAG Diagnostics revenues and CAG Diagnostics capital instrument revenues drove IDEXX (IDXX) Q4 revenues.
- 02/02/2022
|
Idexx Laboratories (IDXX) Tops Q4 Earnings and Revenue Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 13.17% and 2.67%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
- 02/02/2022
|
IDEXX (IDXX) Collaborates With PetDx for Canine Cancer Test
- Following the partnership between IDEXX (IDXX) and PetDx , the test is likely to be available later in January to all veterinary customers of IDXX in the United States and Canada.
- 01/17/2022
|
Idexx Laboratories (IDXX) Gains As Market Dips: What You Should Know
- Idexx Laboratories (IDXX) closed at $661.32 in the latest trading session, marking a +0.86% move from the prior day.
- 12/30/2021
|
IDEXX's (IDXX) Organic Growth Robust, LPD Revenues Decline
- IDEXX's (IDXX) global Reference Lab businesses continue to be robust driven by high same-store volume growth with strong gains across testing categories.
- 12/28/2021
|
Idexx Laboratories (IDXX) Outpaces Stock Market Gains: What You Should Know
- Idexx Laboratories (IDXX) closed at $645.02 in the latest trading session, marking a +0.78% move from the prior day.
- 12/24/2021
|
Idexx Laboratories (IDXX) Dips More Than Broader Markets: What You Should Know
- Idexx Laboratories (IDXX) closed the most recent trading day at $596.35, moving -1.49% from the previous trading session.
- 12/14/2021
|
Idexx Laboratories (IDXX) Outpaces Stock Market Gains: What You Should Know
- Idexx Laboratories (IDXX) closed at $618.55 in the latest trading session, marking a +1.16% move from the prior day.
- 12/08/2021
|
Here's Why You Should Retain IDEXX (IDXX) Stock for Now
- Investors are optimistic about IDEXX's (IDXX) better-than-expected results and continued international growth in the third quarter.
- 12/06/2021
|
IDEXX (IDXX) CAG Placement Grows Globally, LPD Disappoints
- IDEXX' (IDXX) global Reference Lab businesses are robust driven by high same-store volume growth with strong gains across testing categories.
- 11/09/2021
|
IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q3 2021 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q3 2021 Results - Earnings Call Transcript
- 11/02/2021
|
IDEXX (IDXX) Q3 Earnings Beat Estimates, Gross Margin Falls
- IDEXX's (IDXX) Q3 top line rides on strong sales at the CAG and Water businesses.
- 11/02/2021
|
Idexx Laboratories (IDXX) Beats Q3 Earnings and Revenue Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 7.98% and 2.16%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
- 11/02/2021
|
Medical Products Stock Earnings on Nov 2: IDXX, STE & More
- With the pandemic raging on, testing, vaccine and therapeutic makers are witnessing huge market adoption of their COVID-related support products in Q3.
- 11/01/2021
|
Idexx Laboratories (IDXX) Crossed Above the 50-Day Moving Average: What That Means for Investors
- Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
- 11/01/2021
|
4 Medical Products Stocks Poised to Beat This Earnings Season
- Amid concerns surrounding growing COVID-19 cases affecting the medical products companies' legacy business, we are optimistic about IDXX, HSIC, CGC and PODD's results this time around.
- 10/28/2021
|
Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
- Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 10/26/2021
|
IDEXX Laboratories to Release 2021 Third Quarter Financial Results
- WESTBROOK, Maine, Oct. 8, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2021 third quarter financial results for Tuesday, November 2, 2021 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m.
- 10/08/2021
|
3 Stocks Growing Free Cash Flow Fast
- If you are screening the market for investment opportunities among U.S.-listed equities, you may want to consider the stocks listed below, as they have seen their free cash flow increase notably over recent years. As a result, these businesses should be flexible enough to continue to support the development of projects and return cash to shareholders.
- 10/07/2021
|
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
- Is (IDXX) Outperforming Other Medical Stocks This Year?
- 09/28/2021
|
Why Are the Nasdaq's Top Growth Stocks Freaking Out Monday?
- None of it has anything to do with business fundamentals.
- 09/27/2021
|
IDEXX (IDXX) CAG Placement Grows Globally Amid Cost Woes
- IDEXX's (IDXX) global reference lab revenues are growing organically, reflecting growth in the United States and the international markets.
- 09/27/2021
|
Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now
- Investors are optimistic about IDEXX (IDXX) on strong growth in CAG business and solid global performance.
- 09/20/2021
|
Is IDEXX Laboratories (IDXX) Stock Outpacing Its Medical Peers This Year?
- Is (IDXX) Outperforming Other Medical Stocks This Year?
- 09/11/2021
|
4 MedTechs to Gain in 2H21 Beating the Delta Variant-Led Dip
- Investors can choose to invest in MedTech stocks like VREX, OMCL, STAA, and IDXX that have shown tremendous promise amid the pandemic.
- 08/31/2021
|
Nasdaq Clear Winner In Mixed Market; Apple, PYPL, And Idexx In Focus $AAPL $PYPL $IDXX
- Nasdaq clear winner in mixed market; Apple, PYPL, and Idexx in focus. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
- 08/30/2021
|
Nasdaq Clear Winner In Mixed Market; Apple, PYPL, And Idexx In Focus $AAPL $PYPL $IDXX
- Nasdaq clear winner in mixed market; Apple, PYPL, and Idexx in focus. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
- 08/30/2021
|
Idexx (IDXX) is an Incredible Growth Stock: 3 Reasons Why
- Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
- 08/30/2021
|
Stocks Rally On Fed Chief Powell; CrowdStrike Keeps Running; Idexx Labs, Shopify Set Up
- Stocks rally on Fed chief Powell; CrowdStrike keeps running; Idexx Labs, Shopify set up. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
- 08/27/2021
|
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
- Is (IDXX) Outperforming Other Medical Stocks This Year?
- 08/24/2021
|
Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now
- Investors are optimistic about IDEXX (IDXX) on strong growth in CAG business and raised 2021 outlook.
- 08/20/2021
|
3 Smartest Healthcare Stocks to Buy With $1,000 Right Now
- It doesn't take a brainiac to balance risk and reward.
- 08/18/2021
|
Time to Focus on IDEXX Laboratories (IDXX) for Strong Earnings Growth Potential
- If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider IDEXX Laboratories (IDXX).
- 08/17/2021
|
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX)
- Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
- 08/11/2021
|
IDEXX Laboratories to Host Virtual Investor Day
- WESTBROOK, Maine, Aug. 9, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host its 2021 virtual Investor Day on Thursday, August 12, 2021 from 10:00 am to approximately 12:30 pm EDT. The virtual investor day will include executive presentations followed by a question and answer session.
- 08/09/2021
|
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
- Is (IDXX) Outperforming Other Medical Stocks This Year?
- 08/05/2021
|
3 Medical Instruments Stocks Countering Industry Headwinds
- The Zacks Medical - Instruments industry is growing on base business recovery. ISRG, IDXX and ALC are set to gain the most.
- 08/04/2021
|
IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2021 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2021 Results - Earnings Call Transcript
- 07/30/2021
|
IDEXX (IDXX) Q2 Earnings Beat Estimates, 2021 Guidance Up
- Strength in CAG Diagnostics and Water businesses drove IDEXX's (IDXX) second-quarter revenues.
- 07/30/2021
|
Idexx Laboratories (IDXX) Q2 Earnings and Revenues Top Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 16.42% and 5.72%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
- 07/30/2021
|
IDEXX Laboratories Announces Second Quarter Results
- WESTBROOK, Maine, July 30, 2021 /PRNewswire/ -- Achieves reported revenue growth of 30% and organic revenue growth of 25%, driven by CAG Diagnostics recurring revenue growth of 30% as reported and 26% organic Delivers EPS of $2.34, representing 36% growth as reported and 33% on a comparable basis Increases 2021 revenue guidance to $3,170 million - $3,205 million, reflecting higher expectations for reported growth of 17% - 18.5% and organic growth of 14.5% - 16%, supported by projected CAG Diagnostics recurring revenue growth of 18% - 19.5% as reported and 16% - 17.5% organic Raises 2021 EPS outlook to $8.20 - $8.36, reflecting an increase of 1% - 1.5% in the organic revenue growth outlook and expectations for higher operating margins of 28.6% - 29.1% IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced second quarter results, as well as an update on U.S. companion animal diagnostics sector trends. Second Quarter Results The Company reports revenues of $826 million for the second quarter of 2021, an increase of 30% as reported and 25% organically.
- 07/30/2021
|
Why IDEXX Laboratories (IDXX) Might Surprise This Earnings Season
- IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 07/29/2021
|
What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings?
- IDEXX's (IDXX) fiscal second-quarter top line is expected to have benefited from strength in CAG and LPD businesses.
- 07/27/2021
|
IDEXX Laboratories: This Growth Name Is On Fire
- IDEXX Laboratories has seen impressive revenue and margin growth in recent years. It's expanding its cloud presence, and is benefiting from the current pet-friendly environment.
- 07/25/2021
|
Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?
- Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 07/23/2021
|
3 Surprising Stocks That Have Crushed the Market so Far This Year
- They're not the growth stocks you're probably used to being huge winners.
- 07/22/2021
|
Can Idexx (IDXX) Keep the Earnings Surprise Streak Alive?
- Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/20/2021
|
Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today
- Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
- 07/19/2021
|
The InvestorPlace Q&A: Embrace Investing in Momentum With the ProShares QQQA ETF
- Investors should consider the QQQA exchange-traded fund in order to diversify their portfolio with a solid investing philosophy. The post The InvestorPlace Q&A: Embrace Investing in Momentum With the ProShares QQQA ETF appeared first on InvestorPlace.
- 07/07/2021
|
Why Idexx Laboratories Gained 13% in June
- The veterinary products company gained after an acquisition.
- 07/06/2021
|
IDEXX Laboratories to Release 2021 Second Quarter Financial Results
- WESTBROOK, Maine, June 30, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2021 second quarter financial results for Friday, July 30, 2021 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m.
- 06/30/2021
|
What's Next For IDEXX Stock After A 12% Rise In A Month?
- The stock price of IDEXX Laboratories, an animal healthcare company, has seen a rise of 12% in the last twenty-one trading days, while it is up a large 90% over the last one year. This rise can be attributed to the multiple positive developments for the company.
- 06/29/2021
|
Pandemic Boosts Animal Health Spending: 4 Stocks to Buy
- Stocks like PetIQ (PETQ), IDEXX Laboratories (IDXX), Phibro Animal Health (PAHC) and Zoetis (ZTS) offering animal health products and services make great picks for long term.
- 06/29/2021
|
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
- Is (IDXX) Outperforming Other Medical Stocks This Year?
- 06/23/2021
|
Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now
- Investors are optimistic about IDEXX (IDXX) on strong growth in CAG business and bullish 2021 outlook.
- 06/15/2021
|
Overview Of Opportunities In Animal Companionship: A $200B Industry Growing At 6.1% Annually
- The physiological and psychological benefits that pets give us are meaningful. COVID has amplified our appreciation of this. Anticipating 6% annual growth until 2030 may be conservative, even across developed markets.
- 06/11/2021
|
Up 100% in a Year, Can This Animal Health Stock Keep Climbing?
- Not only has Heska stock doubled in a year, it has quintupled over the past five years, and it's a 20-bagger over the last decade. Why is this animal health stock flying so high?
- 06/09/2021
|
Idexx Laboratories (IDXX) Gains As Market Dips: What You Should Know
- Idexx Laboratories (IDXX) closed the most recent trading day at $560.35, moving +0.36% from the previous trading session.
- 06/07/2021
|
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
- Is (IDXX) Outperforming Other Medical Stocks This Year?
- 06/04/2021
|
IDEXX (IDXX) Acquires ezyVet to Boost Practice Management Arm
- The latest acquisition adds to IDEXX's (IDXX) cloud-based practice information management system (PIMS) segment.
- 06/04/2021
|
Why IDEXX (IDXX) Could Be an Impressive Growth Stock
- If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider IDEXX (IDXX).
- 06/03/2021
|
IDEXX Acquires ezyVet
- Global leader in veterinary diagnostics and software enhances its practice management portfolio with acquisition of leading cloud-based solution WESTBROOK, Maine, June 2, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, announced today the acquisition of ezyVet®, a fast-growing, innovative practice information management system (PIMS). With the acquisition, IDEXX further expands its world-class cloud software offerings that support customers with technology solutions that raise the standard of care for patients, improve practice efficiency, and enable more effective communication with pet owners.
- 06/02/2021
|
This News Could Boost Idexx Labs' Earnings for Years to Come
- Idexx Labs reported another strong quarter and provided more details on its new product line.
- 06/02/2021
|
IDEXX Laboratories to Present at Stifel Conference and Announces 2021 Virtual Investor Day
- WESTBROOK, Maine, May 26, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Virtual Jaws & Paws Conference on Wednesday, June 2, 2021. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at 10:00 am (EDT).
- 05/26/2021
|
IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q1 2021 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q1 2021 Results - Earnings Call Transcript
- 05/04/2021
|
IDEXX (IDXX) Earnings Beat Estimates in Q1, '21 View Up
- IDEXX (IDXX) registers strong contribution from its CAG business in the first quarter despite pandemic-induced challenges.
- 05/04/2021
|
Idexx Laboratories (IDXX) Q1 Earnings and Revenues Surpass Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 36.63% and 5.87%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
- 05/04/2021
|
IDEXX Laboratories Announces First Quarter Results
- WESTBROOK, Maine, May 4, 2021 /PRNewswire/ -- Achieves reported revenue growth of 24% and organic growth of 21%, driven by CAG Diagnostics recurring revenue growth of 27% as reported and 23% organic Delivers EPS of $2.35, representing 82% growth as reported and 73% on a comparable basis Increases 2021 revenue guidance to $3,105 million - $3,160 million, reflecting higher expectations for reported growth of 14.5% - 16.5% and organic growth of 13% - 15%, supported by projected CAG Diagnostics recurring revenue growth of 16% - 17.5% as reported and 14.5% - 16% organic Raises 2021 EPS outlook to $7.88 - $8.18, reflecting expectations for 1.5% higher organic revenue growth and targeted operating margin improvement of 270 - 320 basis points as reported and 150 - 200 basis points on a comparable basis IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced first quarter results, as well as an update on U.S. companion animal diagnostics market trends. First Quarter Results The Company reports revenues of $778 million for the first quarter of 2021, an increase of 24% as reported and 21% organic.
- 05/04/2021
|
Idexx Laboratories (IDXX) Stock Moves -0.66%: What You Should Know
- In the latest trading session, Idexx Laboratories (IDXX) closed at $548.99, marking a -0.66% move from the previous day.
- 04/30/2021
|
What's in Store for IDEXX Laboratories (IDXX) in Q1 Earnings?
- IDEXX (IDXX) first-quarter top line is expected to have benefited from strength in CAG and LPD businesses.
- 04/27/2021
|
Stocks This Week: Buy PayPal And Idexx Labs
- This coming week may mark the last thrust up in this equity rally.
- 04/25/2021
|
Market Rally, Leaders Suffer Further Damage: United Airlines, Freeport McMoran, Idexx Labs In Focus
- Market rally suffers further damage, leaders hard hit: United Airlines, Freeport McMoran, Idexx Labs in focus. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data, stock market research, education and the latest financial and business news to help investors make more money in the stock market.
- 04/20/2021
|
IDEXX Laboratories: This Moat-Worthy Name Is Poised To Grow
- IDEXX Laboratories is an industry leader in the field of veterinary health care, and has seen robust growth over the years. It's poised for continued growth, as it continues to scale its revenue base in the current favorable environment for pet adoptions.
- 04/18/2021
|
1 Growth Driver Idexx Shareholders Should be Watching
- The potential is staggering.
- 04/14/2021
|
IDEXX Laboratories to Release 2021 First Quarter Financial Results
- WESTBROOK, Maine, April 8, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2021 first quarter results for Tuesday, May 4, 2021 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m.
- 04/08/2021
|
5 Extremely Overvalued Stocks to Sell Right Now
- Overvalued stocks at record highs for major stock indices are too risky. These 5 stocks are too overvalued to own now.
- 04/08/2021
|
3 Top Pet Healthcare Stocks to Buy Now
- Here's how you can profit off the booming $54 billion veterinary care industry.
- 04/05/2021
|
3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis
- 3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis
- 03/30/2021
|
5 MedTech Growth Stocks Gaining Ground in 2021 Amid Pandemic
- Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.
- 03/25/2021
|
5 Best Stocks Likely to Beat Earnings Estimates
- These top-ranked stocks are likely to beat on the bottom lines in their next releases.
- 03/24/2021
|
Idexx Laboratories (IDXX) Stock Moves -0.76%: What You Should Know
- Idexx Laboratories (IDXX) closed at $487.66 in the latest trading session, marking a -0.76% move from the prior day.
- 03/23/2021
|
IDEXX (IDXX) CAG Placement Grows Sequentially Amid COVID-19 Woes
- IDEXX's (IDXX) Global Reference Lab revenues are growing organically in the United States and in international markets.
- 03/22/2021
|
This Active Investment Fund Has Returned 18.2% Annually
- One of the best-performing investment funds of the last decade is not a secretive Wall Street hedge fund. It's not even a private office or exchange-traded fund.
- 03/19/2021
|
4 Good Companies with High Piotroski F-scores
- In light of the Federal Reserve's announcement that it will pause interest rate hikes through 2023, investors may want to have a look at these four good companies that have strong Piotroski F-scores according to the All-in-One Screener, a Premium feature of GuruFocus: The Home Depot Inc. (NYSE:HD), IDEXX Laboratories Inc. (NASDAQ:IDXX), Moody's Corporation (NYSE:MCO) and Usana Health Sciences Inc. (NYSE:USNA).
- 03/17/2021
|
The Top Holdings of the Decade's Top-Performing Gurus
- Investors often look to top fund managers to glean information on the best strategies and generate new investment ideas.
- 03/16/2021
|
Idexx Laboratories Is a Great High-Margin Growth Play
- Investors in IDEXX stock are betting on continued growth in the company's core business and continued interest by investors in this segment. The post Idexx Laboratories Is a Great High-Margin Growth Play appeared first on InvestorPlace.
- 03/16/2021
|
Here's Why You Should Add IDEXX (IDXX) to Your Portfolio Now
- Investors are optimistic about IDEXX (IDXX) backed by robust CAG and LPD revenues growth and strong global performance boosting the top line.
- 03/16/2021
|
IDEXX Laboratories (IDXX) Sees Hammer Chart Pattern: Time to Buy?
- IDEXX Laboratories (IDXX) has been struggling lately, but the selling pressure may be coming to an end soon
- 03/15/2021
|
3 Pet Med Companies Whose Growth Makes Them a Breed Apart
- The pandemic puppy boom is real, and so are sales for these three pet stocks.
- 03/06/2021
|
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
- Is (IDXX) Outperforming Other Medical Stocks This Year?
- 03/02/2021
|
Are IDEXX, Alphabet & Amazon Poised For Stock Splits In 2021?
- The S&P 500 is up a solid 75% from the lows of March 2020 and many large-cap stocks are now trading near all-time highs. In our indicative theme of Stocks Poised For A Split, we've identified a group of over ten companies from the S&P 500 whose stocks trade at high prices, potentially making.
- 03/01/2021
|
Why This Under-the-Radar Growth Stock Will Be the Top Dog in 2021
- Idexx Labs is an animal health company putting all four feet forward.
- 02/21/2021
|
Love Your Pets? Buy and Hold This Growth Stock for Life, Too
- Idexx Labs is riding the growth trends in pet healthcare.
- 02/19/2021
|
7 Pet Stocks for Animal Lovers and Investors Alike
- Pet stocks have performed very well recently, and many analysts believe that this trend will continue as the industry grows. The post 7 Pet Stocks for Animal Lovers and Investors Alike appeared first on InvestorPlace.
- 02/02/2021
|
IDEXX (IDXX) Earnings Beat Estimates in Q4, Margins Rise
- IDEXX (IDXX) registeres strong contribution from its CAG business in the fourth quarter despite pandemic-induced challenges.
- 02/02/2021
|
IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q4 2020 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q4 2020 Results - Earnings Call Transcript
- 02/02/2021
|
Idexx Laboratories (IDXX) Beats Q4 Earnings and Revenue Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 40.56% and 5.79%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
- 02/02/2021
|
Recap: IDEXX Laboratories Q4 Earnings
- Shares of IDEXX Laboratories (NASDAQ:IDXX) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share were up 69.23% year over year to $1.76, which beat the estimate of $1.40.
- 02/02/2021
|
IDEXX Laboratories Announces Fourth Quarter and Full Year 2020 Results
- WESTBROOK, Maine, Feb. 2, 2021 /PRNewswire/ -- Achieves fourth quarter reported revenue growth of 19% and organic growth of 17%, driven by CAG Diagnostics recurring revenue reported growth of 23% and organic growth of 21% High revenue growth supported by sustained strong global trends in...
- 02/02/2021
|
MedTech Stock Earnings on Feb 2: IDXX, MCK & More
- In Q4, MedTech stocks are expected to have gained from month-wise sales rebound in many states and regions. However, international sales might have been dampened.
- 02/01/2021
|
Earnings Preview for IDEXX Laboratories
- On Tuesday, February 02, IDEXX Laboratories (NASDAQ:IDXX) will release its latest earnings report. Here is Benzinga's outlook for the company.
- 02/01/2021
|
Believe It or Not, There's Something to See With Zomedica
- There's a lot of hype around ZOM stock these days, but the name could prove to be a growth star among pet-related equities. The post Believe It or Not, There's Something to See With Zomedica appeared first on InvestorPlace.
- 01/28/2021
|
What's in Store for IDEXX Laboratories (IDXX) in Q4 Earnings?
- IDEXX's (IDXX) fourth-quarter top line is likely to have benefited from strength in CAG and LPD businesses.
- 01/27/2021
|
The 3 Best Healthcare Stocks to Buy for 2021
- These three healthcare stocks all had a good year in 2020, and their businesses look to have plenty of growth again in 2021.
- 01/23/2021
|
ESG Stocks to Gather Speed Under Biden's Leadership: 5 Picks
- Biden's administration plans to address climate change and take ESG initiatives. This call for investing in Shopify (SHOP), Magna International (MGA), IDEXX Lab (IDXX), Facebook (FB) and PayPal (PYPL).
- 01/20/2021
|
ZOM Stock: Why Zomedica Shares Are on the Move Again Today
- Zomedica shares are surging after the company updated investors on a warrant-redemption cash influx and news that its end-of-March product rollout is on track. Pet-related stocks are hot and ZOM may be on the verge of a significant breakout.
- 01/19/2021
|
Growth In Pet Spending Is Off The Leash, Here Is How To Profit From It
- Rising pet ownership rates and a steadily increasing average household spending provide a powerful tailwind to this investment theme. Pet food, animal health, veterinary equipment, and specialized e-commerce are all fields prone to profit from the secular growth trend.
- 01/12/2021
|
4 of the Best Stocks to Buy for Solid Earnings Growth in 2021
- Earnings growth is considered the most important variable in influencing the share price. Notably, some of the stocks that boast of superb earnings growth include D.R.
- 01/12/2021
|
IDEXX Laboratories to Release 2020 Fourth Quarter and Full-Year Financial Results
- WESTBROOK, Maine, Jan. 11, 2021 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 fourth quarter and full-year financial results for...
- 01/11/2021
|
5 Soaring MedTech Stocks to Buy for More Growth in 2021
- We have selected five MedTech growth stocks with further rooms for improvement in 2021.
- 12/30/2020
|
10 Top-Performing Stocks of the S&P 500 ETF in 2020
- If a Santa Claus rally grips Wall Street in the final days of December, the S&P 500 could see smart gains in 2020 despite the COVID-19 outbreak. These stocks helped the index to hit highs this year.
- 12/28/2020
|
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
- Is (IDXX) Outperforming Other Medical Stocks This Year?
- 12/23/2020
|
8 Pet Stocks That Will Make You Purr
- Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks. The post 8 Pet Stocks That Will Make You Purr appeared first on InvestorPlace.
- 12/23/2020
|
IDEXX (IDXX) Gains on CAG Sales, Global Growth Remains Robust
- IDEXX (IDXX) sees sturdy gains in CAG Diagnostics recurring revenues, supported by high organic gains in both U.S. and International markets.
- 12/21/2020
|
4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2021
- Four large-cap MedTech stocks are currently flourishing on the back of several positive developments
- 12/18/2020
|
5 MedTech Stocks That Have Outperformed the Industry in 2020
- Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.
- 12/17/2020
|
What Makes Idexx Laboratories (IDXX) a Strong Momentum Stock: Buy Now?
- Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 11/27/2020
|
Pet Ownership Is Booming. Could These 3 Stocks Help You Profit?
- Americans treat pets like family members, and that includes spending on specialty food, health services, and insurance.
- 11/27/2020
|
Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?
- Is (IDXX) Outperforming Other Medical Stocks This Year?
- 11/20/2020
|
Should You Be Tempted To ‘Sell' IDEXX Laboratories (IDXX) Stock
- Polen Capital Management recently released its Q3 2020 Investor Letter, a copy of which you can download here. During the third quarter of 2020, the Polen U.S. SMID Company Growth Composite Portfolio returned 7.11% gross of fees, while the Russell 2500 Growth Index was up 9.37%. You should check out Polen Capital's top 5 stock picks for investors to buy right now, which could be the biggest winners of this year.
- 11/13/2020
|
Why It Might Be Time To Pay Attention To These 4 Red-Hot Health Stocks
- The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
- 11/13/2020
|
Which Biotech Stocks Are a Buy on Earnings?
- If you're interested in high-growth biotech stocks with superior fundamentals, here are which ones to consider, and which ones to skip. The post Which Biotech Stocks Are a Buy on Earnings?
- 11/03/2020
|
Were Hedge Funds Right About Loading Up On IDEXX Laboratories, Inc. (IDXX)?
- Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios. In fact, most people expect hedge funds to compete with and outperform the bull market that we have witnessed in recent years. However, hedge funds are generally partially hedged and aim at delivering attractive risk-adjusted returns rather than following the ups and downs of equity markets hoping that they will outperform the broader market. Our research shows that certain hedge funds do have great stock picking skills (and we can identify these hedge funds in advance pretty accurately), so let's take a glance at the smart money sentiment towards IDEXX Laboratories, Inc. (NASDAQ:IDXX).
- 11/02/2020
|
Final Trades: Caterpillar, Apollo, IDEXX & more
- The "Halftime Report" traders give their top picks to watch for the second half.
- 10/30/2020
|
2 Factors That Could Trigger a Major Market Rebound
- Despite the recent volatility, third-quarter earnings season and a "presidential honeymoon" could set off a big market rebound in the near future. Here's more.
- 10/29/2020
|
IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q3 2020 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q3 2020 Results - Earnings Call Transcript
- 10/29/2020
|
IDEXX Laboratories: Q3 Earnings Insights
- Shares of IDEXX Laboratories (NASDAQ:IDXX) were unchanged after the company reported Q3 results.
- 10/29/2020
|
Idexx Laboratories Earnings Growth Soars With Stock In Buy Zone
- Idexx Laboratories earnings and revenue growth were the best in years for the veterinary products supplier. Shares rose after closing in a buy zone.
- 10/29/2020
|
3 MedTech Growth Stocks to Scoop Up Ahead of Q3 Earnings
- Here are three growth stocks from the MedTech space that investors can pick ahead of the quarterly releases.
- 10/16/2020
|
Here's Why Momentum Investors Will Love Idexx Laboratories (IDXX)
- Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 10/14/2020
|
7 Pet Stocks to Adopt Today
- Chewy, Zoetis and FreshPet are just a couple of the names on our list of pet stocks to buy. Let's look at this growing industry more closely.
- 10/13/2020
|
Is Idexx (IDXX) a Solid Growth Stock? 3 Reasons to Think " Yes "
- Idexx (IDXX) possesses solid growth attributes, which could help it handily outperform the market.
- 10/13/2020
|
Why Idexx (IDXX) is Poised to Beat Earnings Estimates Again
- Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 10/13/2020
|
Top Ranked Momentum Stocks to Buy for October 13th
- Top Ranked Momentum Stocks to Buy for October 13th
- 10/13/2020
|
Idexx (IDXX) Hits 52-Week High, Can the Run Continue?
- Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 10/13/2020
|
Veeva Systems, Pool Corp, IDEXX: Stocks That Look Expensive, But Could Outperform
- Our indicative theme on Expensive Performers - which includes companies trading at increasingly higher valuation multiples but are executing well, with consistently expanding Operating Margins and Revenues - is up by about 39% year-to-date on an equally weighted basis.This compares to the S&P 500.
- 10/06/2020
|
IDEXX Laboratories to Release 2020 Third Quarter Financial Results
- WESTBROOK, Maine, Oct. 5, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 third quarter financial results for Thursday, October 29,...
- 10/05/2020
|
Betting Against IDEXX Labs Because of Coronavirus? You May Be Barking Up the Wrong Tree
- This veterinary services-focused company has characteristics that investors love during recessions, but some metrics that may make you turtle up.
- 09/18/2020
|
Idexx (IDXX) Up 2.6% Since Last Earnings Report: Can It Continue?
- Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
- 08/30/2020
|
These 5 Stocks Are The Biggest S&P 500 Healthcare Winners of 2020
- Some of the names on this list may surprise you.
- 08/27/2020
|
These 10 Stocks Are the Biggest S&P 500 Healthcare Winners of 2020
- Savvy investors should consider adding these stocks to their portfolio to enhance its performance and diversity.
- 08/27/2020
|
Idexx Laboratories Climbs Amid Rising Demand For Pet Products
- Idexx Laboratories saw an improvement in its IBD SmartSelect Composite Rating Monday, from 94 to 96.
The post Idexx Laboratories Climbs Amid Rising Demand For Pet Products appeared first on Investor's Business Daily.
- 08/17/2020
|
Top Buys From The Best Money Managers (Q2 2020)
- On August 14th, institutional investment managers with more than $100 million AUM disclosed their positions at the end of Q2 2020.
- 08/16/2020
|
The Economy May Be Struggling, but the Pet Business and the Stock Market Keep Running Strong
- Valuation discomfort can come from high stock multiples and $5-a-pound cartons of grass-fed beef for your dog
- 08/14/2020
|
IDEXX Laboratories Provides U.S. Companion Animal Market Trends Update
- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today provided an update on U.S. Companion Animal Market Trends through Friday, July 31st. For the month of July, U.S. same-store clinical visits increased 6% and U.S. same-store total practice revenue increased 10%, reflecting continued solid trends in companion animal healthcare.
- 08/13/2020
|
IDEXX Laboratories Provides U.S. Companion Animal Market Trends Update
- WESTBROOK, Maine, Aug. 13, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc.
- 08/13/2020
|
IDEXX expands ImageVue digital imaging portfolio, making enhanced radiation safety and superior diagnostic image quality affordable to more veterinarians
- Offers higher image contrast and sharpness, plus reduces radiation dose by 25% or moreWESTBROOK, Maine, Aug. 12, 2020 /CNW/ -- IDEXX Laboratories, Inc.
- 08/12/2020
|
IDEXX launches groundbreaking new ProCyte One Hematology Analyzer with dramatically simplified user experience
- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, announced today the launch of the ProCyte One™ Hematology Analyzer. The new analyzer's advanced technology delivers breakthrough workflow simplicity and consistent, accurate results at the point of care. The ProCyte One Hematology Analyzer is available today for pre-sale in North America and for pre-sale in select European markets later this year, with a global rollout planned for early 2021. The company expects to begin shipping in volume in the first quarter of 2021.
- 08/12/2020
|
IDEXX expands ImageVue digital imaging portfolio, making enhanced radiation safety and superior diagnostic image quality affordable to more veterinarians
- Offers higher image contrast and sharpness, plus reduces radiation dose by 25% or more WESTBROOK, Maine, Aug. 12, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc.
- 08/12/2020
|
IDEXX launches groundbreaking new ProCyte One Hematology Analyzer with dramatically simplified user experience
- Fast, effortless operation and a small footprint make consistent, accurate in-clinic hematology results accessible to veterinarians worldwide WESTBROOK, Maine, Aug. 12, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc.
- 08/12/2020
|
IDEXX Laboratories to Host Virtual Investor Day
- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will host its 2020 virtual Investor Day on Thursday, August 13, 2020 from 10:00 am – 12:00 pm ET.
- 08/10/2020
|
IDEXX Laboratories to Host Virtual Investor Day
- WESTBROOK, Maine, Aug. 10, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc.
- 08/10/2020
|
Global Veterinary Software Market 2020-2025 - Practice Management Software is Expected to Witness a Healthy CAGR - ResearchAndMarkets.com
|
Stocks To Watch: Barrick Gold, Hedge Fund Reveals And Election Plays (NASDAQ:ACIA)
- Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
- 08/08/2020
|
Idexx (IDXX) Soars to 52-Week High, Time to Cash Out?
- Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 08/03/2020
|
Idexx (IDXX) Soars to 52-Week High, Time to Cash Out?
- Idexx (IDXX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
- 08/03/2020
|
Zurcher Kantonalbank Zurich Cantonalbank Has $6.42 Million Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- Zurcher Kantonalbank Zurich Cantonalbank lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 12.2% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,432 shares of the company’s stock after selling 2,696 shares during the quarter. Zurcher Kantonalbank Zurich […]
- 08/01/2020
|
IDEXX Laboratories Inc (IDXX) Q2 2020 Earnings Call Transcript
- IDXX earnings call for the period ending June 29, 2020.
- 07/31/2020
|
IDEXX (IDXX) Earnings Beat Estimates in Q2, Margins Rise
- IDEXX Laboratories (IDXX) registered strong contribution from its CAG business despite the pandemic-led challenges.
- 07/31/2020
|
IDEXX (IDXX) Earnings Beat Estimates in Q2, Margins Rise
- IDEXX Laboratories (IDXX) registered strong contribution from its CAG business despite the pandemic-led challenges.
- 07/31/2020
|
Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year?
- Is (IDXX) Outperforming Other Medical Stocks This Year?
- 07/31/2020
|
IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2020 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc. (IDXX) CEO Jay Mazelsky on Q2 2020 Results - Earnings Call Transcript
- 07/31/2020
|
Idexx Laboratories (IDXX) Beats Q2 Earnings and Revenue Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 43.33% and 9.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 07/31/2020
|
At US$374, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?
- Let's talk about the popular IDEXX Laboratories, Inc. (NASDAQ:IDXX). The company's shares received a lot of attention...
- 07/31/2020
|
Has IDEXX Laboratories (IDXX) Outpaced Other Medical Stocks This Year?
- Is (IDXX) Outperforming Other Medical Stocks This Year?
- 07/31/2020
|
IDEXX Laboratories Announces Second Quarter Results
- Reports revenue growth of 3% on a reported basis and 4% on an organic basis driven by Companion Animal Group Diagnostics recurring revenue growth of 7% reported and organic
- 07/31/2020
|
Idexx Laboratories (IDXX) Beats Q2 Earnings and Revenue Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 43.33% and 9.93%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
- 07/31/2020
|
IDEXX Laboratories Announces Second Quarter Results
- WESTBROOK, Maine, July 31, 2020 /PRNewswire/ -- Reports revenue growth of 3% on a reported basis and 4% on an organic basis driven by Companion Animal Group Diagnostics recurring revenue growth of 7% reported and organic Revenue results supported by global "V-shaped" recovery in the pet.
- 07/31/2020
|
Earnings Scheduled For July 31, 2020
- Companies Reporting Before The Bell
• Chevron Inc. (NYSE:CVX) is expected to report quarterly loss at $0.92 per share on revenue of $22.10 billion.
• Weyerhaeuser Inc. (...
- 07/31/2020
|
Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings?
- IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 07/30/2020
|
Should You Buy IDEXX Laboratories (IDXX) Ahead of Earnings?
- IDEXX Laboratories (IDXX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
- 07/30/2020
|
What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings?
- IDEXX's (IDXX) top line is likely to have benefited from a robust CAG business and regulatory approvals for its COVID-19 tests.
- 07/27/2020
|
What's in Store for IDEXX Laboratories (IDXX) in Q2 Earnings?
- IDEXX's (IDXX) top line is likely to have benefited from a robust CAG business and regulatory approvals for its COVID-19 tests.
- 07/27/2020
|
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Acquired by NEXT Financial Group Inc
- NEXT Financial Group Inc increased its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 22.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,739 shares of the company’s stock after acquiring an additional 319 shares during the quarter. NEXT Financial Group Inc’s holdings in […]
- 07/27/2020
|
3 Great Healthcare Stocks to Watch
- There’s a lot to like about investing in the healthcare sector, so get to know three stocks that make great investments right now.
- 07/24/2020
|
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?
- Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/21/2020
|
Are You Looking for a Top Momentum Pick? Why Idexx Laboratories (IDXX) is a Great Choice
- Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 07/21/2020
|
Will Idexx (IDXX) Beat Estimates Again in Its Next Earnings Report?
- Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/21/2020
|
Are You Looking for a Top Momentum Pick? Why Idexx Laboratories (IDXX) is a Great Choice
- Does Idexx Laboratories (IDXX) have what it takes to be a top stock pick for momentum investors? Let's find out.
- 07/21/2020
|
IDEXX Laboratories to Release 2020 Second Quarter Financial Results and Host Virtual Investor Day
- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2020 second quarter financial results for Friday, July 31, 2020 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
- 07/20/2020
|
Investing For The Long Run: How To Analyze 'Expert' Advice
- My Great Reset Investment Matrix is a helpful guide for analyzing ideas -- including those of famous experts.
- 07/19/2020
|
Investing Ideas For The Long Run: Analyzing 'Expert' Advice
- Stocks Analysis by Jeff Miller covering: Citigroup Inc, Alphabet Inc Class A, Amazon.com Inc, Western Union Company. Read Jeff Miller's latest article on Investing.com
- 07/19/2020
|
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Acquired by Harel Insurance Investments & Financial Services Ltd.
- Harel Insurance Investments & Financial Services Ltd. raised its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 55.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 448 shares of the company’s stock after purchasing an additional 160 shares during the quarter. […]
- 07/16/2020
|
Louisiana State Employees Retirement System Has $1.22 Million Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- Louisiana State Employees Retirement System raised its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 2.8% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 3,700 shares of the company’s stock after acquiring an additional 100 shares during the period. Louisiana State Employees Retirement System’s holdings in IDEXX […]
- 07/16/2020
|
Did Hedge Funds Make The Right Call On IDEXX Laboratories, Inc. (IDXX) ?
- At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile markets we scrutinize hedge fund filings to get a reading on which direction each stock might be going. […]
- 07/14/2020
|
Why IDEXX Laboratories (IDXX) Stock is a Compelling Investment Case
- Baron Asset Fund recently published its second-quarter commentary – a copy of which can be downloaded here. During the second quarter of 2020, the Baron Asset Fund returned 28.02% (institutional shares). In comparison, the benchmark S&P; 500 Index was up 20.54%, while the Russell Midcap Growth Index was up 30.26%. You should check out Baron […]
- 07/13/2020
|
Baron Funds Q2 2020 Andrew Peck Letter
- Baron is an asset management firm focused on delivering growth equity investment solutions known for long-term, fundamental, active approach to growth investing.
- 07/13/2020
|
Carroll Financial Associates Inc. Grows Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- Carroll Financial Associates Inc. grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 50.3% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 269 shares of the company’s stock after buying an additional 90 shares during the quarter. Carroll Financial […]
- 07/13/2020
|
IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests
- IDEXX's (IDXX) human health business, OPTI Medical Systems' newly-developed PCR laboratory test kit named OPTI SARS-CoV-2 RNA RT-PCR gains market acceptance.
- 07/03/2020
|
IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests
- IDEXX's (IDXX) human health business, OPTI Medical Systems' newly-developed PCR laboratory test kit named OPTI SARS-CoV-2 RNA RT-PCR gains market acceptance.
- 07/03/2020
|
IDEXX Gains on Diagnostics Revenues, New Coronavirus Tests
- Stocks Analysis by Zacks Investment Research covering: Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated. Read Zacks Investment Research's latest article on Investing.com
- 07/03/2020
|
Watch briefing: Gov. Mills to speak on reopening, as Maine reports 41 new coronavirus cases
- Another stage of reopening begins Wednesday, as movie theaters, performing arts venues, bowling alleys, amusement parks and spas get a green light to open their doors, provided they follow state protocols.
- 07/01/2020
|
Rumi (cat) needs forever home
- One of your neighbors posted in Community Corner. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
- 06/30/2020
|
Rumi (cat) needs forever home ASAP
- One of your neighbors posted in Neighbor News. Click through to read what they have to say. (The views expressed in this post are the author’s own.)
- 06/30/2020
|
CIO Leadership: HMG Strategy Soars to #1 in Virtual Events for CIOs, CISOs and Technology Executives – Next Up: Virtual Summits in Philadelphia, New York Financial Services and Silicon Valley
- HMG Strategy, the world's #1 digital platform for connecting technology executives to reimagine the enterprise and reshape the business world, is excited to
- 06/29/2020
|
HOLX vs. IDXX: Which Stock Is the Better Value Option?
- HOLX vs. IDXX: Which Stock Is the Better Value Option?
- 06/29/2020
|
HOLX vs. IDXX: Which Stock Is the Better Value Option?
- HOLX vs. IDXX: Which Stock Is the Better Value Option?
- 06/29/2020
|
State of Tennessee Treasury Department Sells 267 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- State of Tennessee Treasury Department lowered its stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 1.3% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 20,169 shares of the company’s stock after selling 267 shares during the […]
- 06/28/2020
|
Global Companion Animal Diagnostics Market (2020 to 2025) - Rising Demand for Pet Insurance is Driving the Market - ResearchAndMarkets.com
|
Coronavirus takes another Maine life, as active cases decline
- The death reported Wednesday brings the Maine toll from COVID-19 to 103 since the pandemic began in March, but the total number of active cases is declining.
- 06/24/2020
|
Assessment of COVID-19's Effect on Small Animal Imaging Market 2020-2024 | Rising Demand for Pet Insurance to Augment Growth | Technavio
- The Global Small Animal Imaging Market will grow by USD 959.08 mn during 2020-2024
- 06/19/2020
|
These 7 Pet Care Stocks Will Reduce the Cost of Pet Ownership
- Global pet care sales could hit $203 billion by 2025. Here are seven pet care stocks to buy from the only pet care ETF in the U.S.
- 06/18/2020
|
These 7 Pet Care Stocks Will Reduce the Cost of Pet Ownership
- The ProShares Pet Care ETF is the only ETF dedicated to pet stocks
- 06/18/2020
|
‘We dodged a lot of bullets’: Quick action at Cape Memory Care limited virus cases in community
- The state's rapid, widespread testing of the residents and staff at the congregate care facility in Cape Elizabeth, coupled with quarantines and tracking and tracing of close contacts, helped contain the spread of COVID-19.
- 06/17/2020
|
Veterinary Immunodiagnostics Industry Report - Global Outlook and Forecast to 2028 - ResearchAndMarkets.com
|
One more death and 17 new COVID-19 cases reported in Maine
- While the number of coronavirus cases tracked by the Maine Center for Disease Control and Prevention continues to increase, deaths of individuals with COVID-19 have remained relatively flat.
- 06/15/2020
|
Quadrupling of state lab’s COVID-19 testing capacity puts Maine in good position, public health experts say
- Beefing up contact tracing and disclosing data about it is the new challenge as the state continues its phased reopening plan.
- 06/14/2020
|
20 Stocks That Are Vulnerable if 2017 Tax Cuts Are Rolled Back
- As the U.S. election nears, strategists expect volatility as investors try to game out what the results could mean for their portfolios and for tax policy.
- 06/13/2020
|
CIO Leadership: HMG Strategy Looks Ahead to UK, Charlotte and St. Louis CIO Virtual Summits After Vaulting to #1 in Virtual Events for CIOs, CTOs, CISOs and Technology Executives
- HMG Strategy, the world's #1 digital platform for connecting technology executives to reimagine the enterprise and reshape the business world, excitedly
- 06/12/2020
|
Forum: Changes in the COVID-19 response
- June is here. In Maine, that usually means days at camp, visits to the beach, hikes, bonfires and lobster dinners. This year, June also means a new stage in the state’s reopening plan. With a pandemic going on around us, it’s hard to know exactly how to act or how to spend our time, but …
- 06/12/2020
|
These 2 States Now Require Summer Visitors To Take A COVID-19 Test
- Summer vacationers have a not-so-difficult choice: Get tested or self-quarantine.
- 06/12/2020
|
US Indexes Mostly Lower Again Wednesday
- Nasdaq reports another new high Continue reading...
- 06/10/2020
|
Maine marks a grim milestone: 100th death from COVID-19
- State health officials reported the 100th death Tuesday, as well as 18 new cases as expanded testing continues.
- 06/09/2020
|
COVID-19 Impact and Recovery Analysis- Veterinary Diagnostic Devices Market 2020-2024 | Rising Demand for Pet Insurance to Boost Growth | Technavio
- The Global Veterinary Diagnostic Devices Market will grow by USD 815.28 mn during 2020-2024
- 06/09/2020
|
Europe Animal Healthcare Market Analysis and Demand With Forecast Overview To 2026
- Jun 08, 2020 (Market Insight Reports) --
Selbyville, Delaware: Europe Animal Healthcare market report studies the industry based on one or more segments...
- 06/08/2020
|
Maine eases quarantine rule for visitors as virus testing expands
- Vermont and New Hampshire residents will not have to quarantine, and other visitors can avoid the 14-day quarantine if they certify they have tested negative for COVID-19 within 72 hours before checking in to a Maine lodging.
- 06/08/2020
|
Maine lifts some tourism restrictions, announces plan to quadruple testing capacity in July - The Boston Globe
- Maine announced it will quadruple its coronavirus testing capacity in July, as the state reported 18 new cases of the virus and no new deaths.
- 06/08/2020
|
IDEXX OPTI Medical Gets CE Mark for RT-PCR Coronavirus Test
- This test by IDEXX (IDXX) benefits from an optimized workflow and claims to deliver greater assurance of quality and accuracy.
- 06/08/2020
|
IDEXX OPTI Medical Gets CE Mark for RT-PCR Coronavirus Test
- This test by IDEXX (IDXX) benefits from an optimized workflow and claims to deliver greater assurance of quality and accuracy.
- 06/08/2020
|
Idexx Unit Gets European Union Regulatory Nod For Covid-19 Test Kit
- Idexx Laboratories Inc.’s (IDXX) subsidiary Opti Medical Systems, Inc., announced that it has received the European Union’s regulatory CE mark approval for its laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19.The Opti SARS-CoV-2 test kit uses real-time reverse transcription polymerase chain reaction (RT-PCR) technology and is developed to provide results in about 2–3.5 hours."The CE mark certification is an important step in advancing our efforts to support critical COVID-19 testing,” said Olivier te Boekhorst, Corporate VP and General Manager of Opti Medical Systems. “We are committed to helping our communities around the globe and will continue to work with regulatory authorities and customers to expand the availability of diagnostic testing.”In addition, the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for Opti’s DNA/RNA magnetic bead kit for nucleic acid extraction from respiratory samples to be used with the Opti SARS-CoV-2 RT-PCR test kit. This will enable Opti Medical Systems to provide laboratories with a complete manufactured workflow solution for COVID-19 testing, the company said.Opti’s RT-PCR laboratory test kit has previously been approved by the Institut Pasteur of France and has also received EUA by the FDA.Shares in Idexx Laboratories have climbed about 70% since reaching a multi-year low in March. The stock rose 0.5% to $311.71 as of Friday’s close.Five-star analyst Erin Wright at Credit Suisse recently reiterated his Buy rating on the stock with a $300 price target, as weekly clinical visit trends turn positive.“While we acknowledge near-term COVID-19 headwinds remain, the reported patient visit growth underscores our view of IDXX as a compelling alternative investment, with durable revenues and consistent price realization in a healthy longer term fundamental backdrop, contributing to greater predictability and visibility on growth,” Wright wrote in a note to investors.The rest of the Wall Street analyst community is cautiously optimistic on Idexx stock. The Moderate Buy consensus consists of 3 Buy versus 2 Hold ratings. The $300.75 average price target now indicates 3.5% downside potential in the shares, following the sharp rally this year. (See Idexx stock analysis on TipRanks).Related News: AbbVie Announces Partnership To Develop Novel Covid-19 Antibody Therapy Emergent Bio Plunges 14% Post-Market After Directors Divest Shares 5 Promising Covid-19 Vaccines Picked For Trump’s Operation Warp Speed More recent articles from Smarter Analyst: * Boeing (BA) Stock Probably Rallied Too Far, Too Fast * Latam Airlines' Shares Could Be Heading Further South; Top Analyst Says 'Sell' * Starbucks’ (SBUX) Road to Recovery Will Take Longer Than Anticipated, Says Analyst * TripAdvisor: Post Pandemic, Many Challenges Await
- 06/07/2020
|
Ladislas Nzeyimana: Deering High School
- He has become a school and community leader after only four years in the United States.
- 06/07/2020
|
Private Advisor Group LLC Sells 2,756 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- Private Advisor Group LLC decreased its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 35.8% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,939 shares of the company’s stock after selling 2,756 shares during the period. Private Advisor […]
- 06/07/2020
|
Is IDEXX Laboratories, Inc. (IDXX) A Good Stock To Buy?
- Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
- 06/05/2020
|
OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
- OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced that it has received the CE mark certification in the European Union for its OPTI® SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19. This announcement follows earlier validation of the test by the Institut Pasteur of France as well as Emergency Use Authorization (EUA) by the United States Food and Drug Administration (FDA).
- 06/05/2020
|
OPTI Medical Systems Receives CE Mark for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
- ROSWELL, Ga., and WESTBROOK, Maine, June 5, 2020 /PRNewswire/ -- OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced that it has received the CE mark certification in the European Union for its OPTI® SARS-CoV-2 RT-PCR laboratory test kit...
- 06/05/2020
|
Stocks That Hit 52-Week Highs On Thursday
|
Stocks That Hit 52-Week Highs On Wednesday
|
Veterinary Rapid Tests Market 2020-2024 | Increasing Prevalence of Zoonotic Diseases to Boost Growth | Technavio
- The Global Veterinary Rapid Tests Market will grow by $ 228.69 bn during 2020-2024
- 06/03/2020
|
Stocks That Hit 52-Week Highs On Monday
|
Idexx (IDXX) Up 11.3% Since Last Earnings Report: Can It Continue?
- Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- 05/30/2020
|
Idexx (IDXX) Up 11.3% Since Last Earnings Report: Can It Continue?
- Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
- 05/30/2020
|
The global veterinary point-of-care diagnostics market size is projected to reach USD 2.4 billion by 2025 from USD 1.4 billion in 2019, at a CAGR of 8.9%
- NEW YORK, May 29, 2020 /PRNewswire via COMTEX/ --
NEW YORK, May 29, 2020 /PRNewswire/ -- The global veterinary point-of-care diagnostics market is projected...
- 05/29/2020
|
Stocks That Hit 52-Week Highs On Thursday
|
Zacks.com featured highlights include: Myriad Genetics, Cinemark, Vericel and IDEXX Laboratories
- Zacks.com featured highlights include: Myriad Genetics, Cinemark, Vericel and IDEXX Laboratories
- 05/27/2020
|
IDEXX Sees Higher Clinical Visits Despite Coronavirus Crisis
- IDEXX (IDXX) notes a significant improvement in U.S. clinical visit trends across major regions.
- 05/27/2020
|
IDEXX Sees Higher Clinical Visits Despite Coronavirus Crisis
- IDEXX (IDXX) notes a significant improvement in U.S. clinical visit trends across major regions.
- 05/27/2020
|
IDEXX Laboratories Provides U.S. Companion Animal Market Trends Update
- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today provided an update on U.S. Companion Animal Market Trends through Friday, May 22nd.
- 05/26/2020
|
Maine to expand contact tracing for coronavirus exposures
- The state will use $7.5 million in federal funds to hire more staff to identify those who may have had contact with infected people, and it is using new technology to allow people in quarantine to report symptoms.
- 05/26/2020
|
Dump These 4 Toxic Stocks or Sell Short for Timely Profits
- Identifying toxic stocks and discarding them at the right time is the key to guard your portfolio from big losses.
- 05/26/2020
|
Dump These 4 Toxic Stocks or Sell Short for Timely Profits
- Identifying toxic stocks and discarding them at the right time is the key to guard your portfolio from big losses.
- 05/26/2020
|
Great Animal Imaging Market Boosting the Growth Worldwide: 2026 Market Key Dynamics, Recent and Future Demand, Trends, Share Valuation Industry Size and Foreseen Research Report
- May 26, 2020 (Profound via COMTEX) --
Great Animal Imaging Market 2020 Report offers a professional and in-depth study on the current state of the Global...
- 05/26/2020
|
Global Animal Pharmaceuticals Market (2020 to 2025) - By Product Type, Product, Animal Type, Registration, Region, Forecast & Opportunities - ResearchAndMarkets.com
|
Veterinary Diagnostic Imaging Market Size, Share and Global Outlook During 2020 to 2026; Toshiba, Carestream Health, BCF Technology
- May 25, 2020 (Market Insight Reports) --
The Veterinary Diagnostic Imaging Market recently published a Global Market research study with more than 100...
- 05/25/2020
|
Insider Weekends: Moderna Executives Go On A Selling Spree
- Insider buying decreased significantly last week. Notable Insider Buys: Mercury General Corporation, Cortexyme, Inc., New Mountain Finance Corporation, Berkshir
- 05/25/2020
|
Have $1,000 to Invest? Billionaires Are Buying These 3 Stocks
- You could ask 100 different analysts what they think about buying and selling stocks during COVID-19, and you might just get 100 different opinions. If you have $1,000 to invest, now could be a great opportunity to start a new position, and billion-dollar hedge fund managers have been scooping up shares of IDEXX Laboratories (NASDAQ: IDXX), Goodyear Tire (NASDAQ: GT) and Starbucks (NASDAQ: SBUX). You may not recognize IDEXX Laboratories, but if you're a pet owner there's a chance you've crossed paths with its products or services already.
- 05/25/2020
|
Have $1,000 to Invest? Billionaires Are Buying These 3 Stocks
- It's easy to see why the smart money is moving into these three stocks.
- 05/25/2020
|
Research Report with COVID-19 Forecasts- Animal Health Diagnostics Market 2020-2024 | Rising Pet Adoption to Boost Growth | Technavio
- The animal health diagnostics market is poised to grow by USD 1.69 bn during 2020-2024, according to Technavio
- 05/23/2020
|
CIO Leadership: HMG Strategy Smashes Attendance Records with its Silicon Valley CISO Virtual Summit on May 21 – Next Up: Denver CIO Virtual Summit
- In the latest in its ongoing series of HMG Live! Virtual CIO and CISO Summits, HMG Strategy is excited to announce that its Silicon Valley CISO Virtual Summit
- 05/22/2020
|
Urgent care, walk-in clinics making virus tests easier to get in Maine
- Expanded testing will also include drive-through sites, although patients still will need to be screened by medical providers before being tested.
- 05/22/2020
|
State reports new outbreak of 57 cases at long-term care facility in Cape Elizabeth
- The outbreak at Cape Memory Care is the largest reported at one time in Maine, and more test results are still pending.
- 05/21/2020
|
Maine sees jump in coronavirus infections with 78 new cases
- Wednesday's spike is attributed in part to increased testing capacity at state and private labs, and comes at a time when the racial gap among those with COVID-19 is growing.
- 05/20/2020
|
Maine delays gym openings as CDC reports 3 deaths, 28 additional COVID-19 cases
- While the reopening of gyms, fitness centers and nail salons will be delayed because of concerns about virus transmission, campgrounds will be allowed to reopen this weekend to Maine residents, about a week ahead of the original plan.
- 05/19/2020
|
IDEXX Laboratories to Present at Stifel Conference
- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Virtual Jaws & Paws Conference on Wednesday, May 27, 2020. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a virtual fireside chat at 9:45 am EDT.
- 05/18/2020
|
Stocks That Hit 52-Week Highs On Monday
|
IDEXX Laboratories to Present at Stifel Conference
- WESTBROOK, Maine, May 18, 2020 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate in the Stifel Virtual Jaws & Paws Conference on Wednesday, May 27, 2020. Jay...
- 05/18/2020
|
Google Stock And Two Others Join IBD's Long-Term Leaders Watchlist
- Google stock forms a bullish cup base. It joins IBD's Long-Term Leaders Watchlist along with two others.
- 05/15/2020
|
Night Owl Capital Management, LLC Buys Fidelity National Information Services Inc, Aon PLC, ...
|
Summit Global Investments Buys Amazon.com Inc, Clorox Co, Adobe Inc, Sells NVR Inc, TJX Inc, ...
|
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
- Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
- 05/13/2020
|
MayTech Global Investments, LLC Buys Facebook Inc, Sea, Livongo Health Inc, Sells iShares Core ...
|
Veterinary Diagnostics Market to Reach US$ 5.4 Bn by 2027
- May 11, 2020 (Market Prediction via COMTEX) --
The global Veterinary Diagnostics Market is projected to reach more than US$ 5.4 Billion By 2027 with a CAGR...
- 05/11/2020
|
Blair William & Co Buys Apple Inc, Microsoft Corp, Amazon.com Inc
|
Mills announces accelerated reopening for retail stores, restaurants in 12 rural counties
- The announcement comes one day after Gov. Janet Mills unveiled a deal with Westbrook-based Idexx that will allow the state's public health lab to triple its testing capacity.
- 05/08/2020
|
Stocks That Hit 52-Week Highs On Friday
|
Benzinga Pro's Top 5 Stocks To Watch For Fri., May 8, 2020: KC, IDXX, LAZY, AQST, AN
- Today's 5 Stock Ideas: * Kingsoft Cloud (KC) \- A new issue expected to open Friday morning. The company is one of China's top cloud service providers. Shares were expected in the $16-$18/share range and priced right in the middle at $17/share. * IDEXX (IDXX) \- A play on coronavirus testing. The company reported its OPTI Medical subsidiary was granted FDA Emergency Use Authorization for OPTI coronavirus lab test kit. * Lazydays (LAZY) \- A play on the RV market. Public health workers and nurses have recently used RVs as a way to effectively separate their home environment from their families. * Aquestive Therapeutics (AQST) \- A play on an upcoming FDA date. The company is expected see an FDA PDUFA action date for its Parkinson's treatment New Drug Application within the next two weeks. * AutoNation (AN) - An earnings play. The company will report quarterly results before the market open on Monday.See more from Benzinga * Benzinga Pro's Top 5 Stocks To Watch For Fri., Apr. 3, 2020: USIO, NTDOY, AJRD, AN, OTIS(C) 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
- 05/08/2020
|
Dai-Ichi Life Insurance Company, Ltd Buys Lockheed Martin Corp, Bright Horizons Family ...
|
Maine to triple its virus testing capacity in partnership with Idexx
- Gov. Janet Mills says that, soon, anyone who needs a coronavirus test will be able to get one.
- 05/07/2020
|
'Gov. Mills says Maine is about to triple the number of #COVID19 tests in the state in partnership with IDEXX, allowing anyone in Maine suspected of having the virus to get a test' -Tweet
|
IDEXX Labs Reports Its OPTI Medical Subsidiary Granted FDA Emergency Use Authorization For OPTI Coronavirus Lab Test Kit
|
OPTI Medical Systems Receives US FDA Emergency Use Authorization for Its OPTI SARS-CoV-2 RNA PCR Test Kit for Detection of the Virus Causing COVID-19
- OPTI Medical Systems, Inc., a subsidiary of IDEXX Laboratories, Inc. (NASDAQ: IDXX), today announced that the United States Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for the OPTI® SARS-CoV-2 RT-PCR laboratory test kit for the detection of SARS-CoV-2, the virus that causes COVID-19. This announcement follows earlier validation of the test by the Institut Pasteur of France.
- 05/07/2020
|
Cqs (us), Llc Buys Merck Inc, Johnson & Johnson, Kimberly-Clark Corp, Sells Discovery Inc, ...
|
Elanco Animal Health: An Unnoticed Stock With Potential
- Elanco Animal Health Inc. is buying Bayer’s animal health unit. Elanco has underperformed the overall market and rivals. With new product launches, Elanco looks
- 05/06/2020
|
Veterinary Reference Laboratory (VRL) Market 2020 | COVID -19 Research Report- IDEXX Laboratories, Inc., VCA, Inc., GD Animal Health, Greencross Ltd
- May 05, 2020 Xherald --
Veterinary Reference Laboratory (VRL) Market report will make detailed analysis mainly on in-depth research on the development...
- 05/05/2020
|
Stifel Maintains Buy on IDEXX Laboratories, Raises Price Target to $280
|
IDEXX Laboratories Inc (IDXX) Q1 2020 Earnings Call Transcript
- IDXX earnings call for the period ending March 31, 2020.
- 05/01/2020
|
Edited Transcript of IDXX earnings conference call or presentation 30-Apr-20 12:30pm GMT
- Q1 2020 IDEXX Laboratories Inc Earnings Call
- 04/30/2020
|
IDEXX Laboratories, Inc.'s (IDXX) CEO Jay Mazelsky on Q1 2020 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2020 Results Earnings Conference Call April 30, 2020, 8:30 AM ET Company Participants Jay Mazelsky - President and CEO
- 04/30/2020
|
Idexx Laboratories Tops Q1 Estimates Despite COVID-19 Impact
- The company withdrew its full-year guidance because of the COVID-19 pandemic but is seeing some signs of improvement in April.
- 04/30/2020
|
IDEXX Laboratories, Inc.'s (IDXX) CEO Jay Mazelsky on Q1 2020 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc.'s (IDXX) CEO Jay Mazelsky on Q1 2020 Results - Earnings Call Transcript
- 04/30/2020
|
IDEXX: The Size Of The Fight In The Dog
- “What counts is not the size of the dog in the fight - it's the size of the fight in the dog” (Mark Twain); COVID-19 will probably hurt IDEXX, but this company
- 04/30/2020
|
IDEXX (IDXX) Q1 Earnings Top Estimates, Margins Decline
- IDEXX Laboratories (IDXX) companion animal clinical visits decrease due to the impact of the coronavirus pandemic.
- 04/30/2020
|
IDEXX (IDXX) Q1 Earnings Top Estimates, Margins Decline
- IDEXX Laboratories (IDXX) companion animal clinical visits decrease due to the impact of the coronavirus pandemic.
- 04/30/2020
|
Idexx Laboratories Tops Q1 Estimates Despite COVID-19 Impact
- The company withdrew its full-year guidance because of the COVID-19 pandemic but is seeing some signs of improvement in April.
- 04/30/2020
|
Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 4.88% and -0.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 04/30/2020
|
Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 4.88% and -0.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 04/30/2020
|
IDEXX (IDXX) Q1 Earnings Top Estimates, Margins Decline
- IDEXX Laboratories (IDXX) companion animal clinical visits decrease due to the impact of the coronavirus pandemic.
- 04/30/2020
|
Idexx: 1Q Earnings Snapshot
- WESTBROOK, Maine (AP) _ Idexx Laboratories Inc. (IDXX) on Thursday reported first-quarter profit of $111.8 million.
On a per-share basis, the Westbrook, Maine-based company said it had profit of $1.29.
The results beat Wall Street expectations. The a
- 04/30/2020
|
Idexx Laboratories (IDXX) Beats Q1 Earnings Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 4.88% and -0.86%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
- 04/30/2020
|
IDEXX Laboratories Q1 EPS $1.290 Beats $1.200 Estimate, Sales $626.336M Beat $617.410M Estimate
|
Notable earnings before Thursday's open
- AAL, ABMD, AGIO, AIMC, AIT, AMRN, ARW, ASPS, AUY, BAX, BC, BEN, BPOP, CFR, CG, CHD, CI, CMCSA, COLB, COP, COR, CRS, CWT, DAN, DNKN, DOW, EME, ESI, ETN, FBP, FCN, FLWS, GNRC, GRA, GT, HBI, HGV, HUBB, I
- 04/29/2020
|
IDEXX Laboratories Q1 2020 Earnings Preview
- IDEXX Laboratories (NASDAQ:IDXX) is scheduled to announce Q1 earnings results on Thursday, April 30th, before market open.The consensus EPS Estimate is $1.20 (+2.6% Y/Y) and the consensus Revenue Esti
- 04/29/2020
|
Medical Products Stock Earnings on Apr 30: BAX, IDXX & More
- The medical product companies have partially mitigated the impact of the pandemic driven by the massive adoption of COVID-19 related healthcare-support products and services.
- 04/29/2020
|
Medical Products Stock Earnings on Apr 30: BAX, IDXX & More
- The medical product companies have partially mitigated the impact of the pandemic driven by the massive adoption of COVID-19 related healthcare-support products and services.
- 04/29/2020
|
BBVA USA Bancshares Inc. Buys 135 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- BBVA USA Bancshares Inc. lifted its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 4.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,311 shares of the company’s stock after acquiring an additional 135 shares during the period. BBVA USA Bancshares Inc.’s […]
- 04/29/2020
|
Can my dog or cat get coronavirus? What pet owners need to know after a pug and two cats tested positive in the U.S.
- Here’s how to take care of pets during the COVID-19 pandemic
- 04/28/2020
|
Clarius Group LLC Acquires 77 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- Clarius Group LLC raised its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 8.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 947 shares of the company’s stock after acquiring an additional 77 shares during the period. Clarius Group LLC’s […]
- 04/28/2020
|
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Short Interest Up 37.1% in April
- IDEXX Laboratories, Inc. (NASDAQ:IDXX) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 2,070,000 shares, a growth of 37.1% from the March 31st total of 1,510,000 shares. Based on an average daily volume of 713,700 shares, the days-to-cover ratio is […]
- 04/28/2020
|
Torray LLC Buys Bristol-Myers Squibb Company, Sysco Corp, DuPont de Nemours Inc, Sells General ...
|
Hartford Investment Management Co. Has $2.26 Million Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- Hartford Investment Management Co. grew its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 3.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 9,317 shares of the company’s stock after purchasing an additional 317 shares during the period. Hartford Investment Management Co.’s holdings in IDEXX […]
- 04/27/2020
|
Top-Rated Idexx Laboratories Near Buy Zone With Earnings Due
|
Cribstone Capital Management LLC Has $1.49 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- Cribstone Capital Management LLC decreased its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 2.5% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,165 shares of the company’s stock after selling 155 shares during the quarter. IDEXX Laboratories accounts for approximately 1.6% of […]
- 04/26/2020
|
Analysts Expect IDEXX Laboratories, Inc. (NASDAQ:IDXX) Will Announce Quarterly Sales of $631.77 Million
- Equities research analysts expect IDEXX Laboratories, Inc. (NASDAQ:IDXX) to post sales of $631.77 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for IDEXX Laboratories’ earnings, with the lowest sales estimate coming in at $625.20 million and the highest estimate coming in at $637.50 million. IDEXX Laboratories posted sales of $576.06 […]
- 04/26/2020
|
Cabot Wealth Management Inc. Has $978,000 Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- Cabot Wealth Management Inc. trimmed its holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 1.6% during the first quarter, Holdings Channel reports. The firm owned 4,037 shares of the company’s stock after selling 65 shares during the quarter. Cabot Wealth Management Inc.’s holdings in IDEXX Laboratories were worth $978,000 at the end of the most recent […]
- 04/24/2020
|
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
- Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/23/2020
|
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
- Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/23/2020
|
What's in Store for IDEXX Laboratories (IDXX) in Q1 Earnings?
- IDEXX's (IDXX) business is likely to have benefited from few cases in which pets were found to be COVID-19 positive globally.
- 04/23/2020
|
What's in Store for IDEXX Laboratories (IDXX) in Q1 Earnings?
- IDEXX's (IDXX) business is likely to have benefited from few cases in which pets were found to be COVID-19 positive globally.
- 04/23/2020
|
Two New York cats become first U.S. pets to test positive for COVID-19
|
Idexx Laboratories (IDXX) Reports Next Week: Wall Street Expects Earnings Growth
- Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 04/23/2020
|
What's in Store for IDEXX Laboratories (IDXX) in Q1 Earnings?
- IDEXX's (IDXX) business is likely to have benefited from few cases in which pets were found to be COVID-19 positive globally.
- 04/23/2020
|
IDEXX Laboratories (IDXX) Scheduled to Post Earnings on Thursday
- IDEXX Laboratories (NASDAQ:IDXX) is scheduled to be releasing its earnings data before the market opens on Thursday, April 30th. Analysts expect IDEXX Laboratories to post earnings of $1.21 per share for the quarter. IDEXX Laboratories has set its FY 2020 Pre-Market guidance at 5.42-5.58 EPS and its FY20 guidance at $5.42-5.58 EPS.Persons that are interested […]
- 04/23/2020
|
Two New York cats become first U.S. pets to test positive for COVID-19
- Two cats in New York have become the first pets in the United States to test positive for the new coronavirus but there is no evidence pets can spread the virus to humans, according to U.S. health …
- 04/23/2020
|
UPDATE 2-Two New York cats become first U.S. pets to test positive for COVID-19
- Two cats in New York have become the first pets in the United States to test positive for the new coronavirus but there is no evidence pets can spread the virus to humans, according to U.S. health authorities.
- 04/23/2020
|
Anderson Hoagland & Co Buys Vanguard Total Stock Market, Microsoft Corp, Alibaba Group ...
|
Edited Transcript of CEVI.ST earnings conference call or presentation 22-Apr-20 9:00am GMT
- Q1 2020 CellaVision AB Earnings Call
- 04/22/2020
|
IDEXX Laboratories: A Best-In-Breed Growth Company
- IDEXX Laboratories sports an impressive return on invested capital and the business is benefiting from increased spending on pets. IDEXX shares have appreciated
- 04/22/2020
|
400 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Bought by CENTRAL TRUST Co
- CENTRAL TRUST Co purchased a new position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 400 shares of the company’s stock, valued at approximately $97,000. A number of other institutional investors and hedge funds also recently modified […]
- 04/22/2020
|
Assenagon Asset Management S.A. Sells 12,892 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- Assenagon Asset Management S.A. cut its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 66.5% in the 1st quarter, HoldingsChannel reports. The fund owned 6,505 shares of the company’s stock after selling 12,892 shares during the period. Assenagon Asset Management S.A.’s holdings in IDEXX Laboratories were worth $1,576,000 as of its most recent SEC […]
- 04/22/2020
|
Congress Asset Management Co Buys Ciena Corp, Huntington Ingalls Industries Inc, Akamai ...
|
Stay-home foes heading to Augusta; elders getting groceries
- PORTLAND, Maine (AP) — The latest demonstration aimed at reopening the economy as the coronavirus pandemic eases and ending stay-at-home restrictions is scheduled to take place in Maine's capital city on Monday. Similar rallies have happened in New Hampshire, Michigan and elsewhere in the country, with participants including gun rights activists, opponents of stay-at-home orders and fans of Republican President Donald Trump. Maine's event is organized by Republican State Rep. Chris Johansen, of Aroostook County. Johansen has urged participants in the rally to maintain social distance, wear masks and abstain from openly carrying guns. He has also used social media to call on demonstrators to “fill up your gas tanks and get ready to rumble" in Augusta. The event will include a “motor brigade,” in which residents will circle the governor's mansion in vehicles, and a sidewalk rally. Johansen has told participants to wear Trump's signature “Make American Great Again” hats and bring bullhorns. Social media posts about the demonstration direct their ire at Democratic Gov. Janet Mills, who has placed the state under a stay-at-home order. ___ REPUBLICANS VOICE CONCERNS Dozens of Republican lawmakers sent a letter to Mills on Sunday calling for better communication between the governor's office and GOP legislators. The Republicans charged that they are learning of policy changes via Mills' news conference instead of being informed about them beforehand. They cited Mills' extension of Maine's “state of civil emergency," which she pushed to May 15 last week. The GOP members also wrote that they are concerned about what plans are being made to reopen business in Maine. “We know the department is very busy but also believe it is imperative that plans have begun to...
- 04/20/2020
|
IDEXX Labs launches COVID-19 test for pets amid rare cases of human-to-pet transmission
- IDEXX Laboratories Inc said on Monday it would provide veterinarians a COVID-19 test for pets amid evidence that infected humans could transmit the virus to their pets.
- 04/20/2020
|
IDEXX Labs launches COVID-19 test for pets amid rare cases of human-to-pet transmission
- IDEXX Laboratories Inc said on Monday it would provide veterinarians a COVID-19 test for pets amid evidence that infected humans could transmit the virus to their pets.The company advised that vete…
- 04/20/2020
|
IDEXX Labs launches COVID-19 test for pets amid rare cases of human-to-pet transmission
- IDEXX Laboratories Inc said on Monday it would provide veterinarians a COVID-19 test for pets amid evidence that infected humans could transmit the virus to their pets. The company advised that veterinarians order the test after consulting a public health authority and only if other common infections have been ruled out in pets showing symptoms and those that have been living in a household with an infected person. Earlier this month, researchers found that cats and ferrets could catch the coronavirus, prompting the World Health Organization to say it will take a closer look at transmission of the virus between humans and pets.
- 04/20/2020
|
BRIEF-Idexx Makes Pet Test For COVID-19 Virus Available To Veterinarians
- IDEXX Laboratories Inc:
- 04/20/2020
|
IDEXX Makes Pet Test for COVID-19 Virus Available to Veterinarians
- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics and software, today announced the availability of the IDEXX SARS-CoV-2 (COVID-19) RealPCR™ Test for pets. IDEXX is launching the test in response to customer demand and growing evidence that in rare cases pets living with COVID-19 positive humans can be at risk for SARS-CoV-2 infection. The test will be available to veterinarians in North America this week and will continue to roll out across most of the world in the coming weeks, enabled by IDEXX Reference Laboratories, the company's worldwide network of more than 80 laboratories.
- 04/20/2020
|
Top-Rated Stocks Near Buy Point With Earnings Due: Idexx Laboratories
|
Las mascotas son víctimas del coronavirus, pero no lo contagian
- El 3 de marzo, los servicios sanitarios de Hong Kong realizaron pruebas a 27 perros y 15 gatos que guardaban cuarentena por haber convivido con humanos contagiados. Solamente dos perros y un gato dieron positivo a las pruebas del coronavirus
- 04/18/2020
|
What Is IDEXX Laboratories's (NASDAQ:IDXX) P/E Ratio After Its Share Price Rocketed?
- IDEXX Laboratories (NASDAQ:IDXX) shareholders are no doubt pleased to see that the share price has bounced 37% in the...
- 04/18/2020
|
How Does IDEXX Laboratories’s (NASDAQ:IDXX) P/E Compare To Its Industry, After Its Big Share Price Gain?
- Those holding IDEXX Laboratories (NASDAQ:IDXX) shares must be pleased that the share price has rebounded 37% in the...
- 04/18/2020
|
Donaldson Capital Management LLC Grows Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
- Donaldson Capital Management LLC increased its position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 29.7% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,710 shares of the company’s stock after acquiring an additional 392 shares during the quarter. Donaldson Capital Management LLC’s holdings […]
- 04/17/2020
|
BRIEF-IDEXX Laboratories Inc Enters Second Amendment To Note Purchase And Private Shelf Agreement
- IDEXX Laboratories Inc:
- 04/16/2020
|
Coronavirus Hits S&P 500: 4 MedTech Stocks That Fared Better
- Here are a few MedTech companies which have outperformed the S&P 500 index in the past two months.
- 04/03/2020
|
IDEXX's (IDXX) CAG Arm Grows Strong on Product Launches
- Product launches like Cornerstone, Neo, Animana aid IDEXX' (IDXX) CAG business.
- 04/03/2020
|
Is IDEXX Laboratories Stock a Buy?
- What's the verdict on this animal healthcare company?
- 03/14/2020
|
WHO Says There's No Evidence That Pets Can Pass Coronavirus to Humans
- But now, the agency isn't so sure about whether people can transmit the disease to dogs and cats.
- 03/13/2020
|
5 Must-Buy S&P 500 Large-Cap Growth Stocks at a Discount
- As a result of regular market fluctuations, several growth stocks have become ultra-cheap at present, some of which have strong growth potential.
- 03/05/2020
|
IDEXX Laboratories: A Widening Moat and a Massive Runway Ahead
- “Dog is a man’s best friend.” This old saying has seen its business implications increasing these days.
- 03/04/2020
|
Why Is Idexx (IDXX) Down 10.3% Since Last Earnings Report?
- Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
- 03/01/2020
|
Here's Why You Should Retain IDEXX Laboratories Stock Now
- Investor confidence remains high in IDEXX (IDXX) stock, thanks to solid prospects.
- 02/05/2020
|
IDEXX Laboratories, Inc. (IDXX) CEO Jonathan Mazelsky on Q4 2019 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc. (IDXX) CEO Jonathan Mazelsky on Q4 2019 Results - Earnings Call Transcript
- 01/31/2020
|
How Idexx Laboratories Beat Expectations in Q4
- The animal health company boosted its full-year 2020 earnings guidance, too.
- 01/31/2020
|
IDEXX (IDXX) Q4 Earnings Top Estimates, Revenues Grow Y/Y
- The year-over-year upside in IDEXX's (IDXX) revenues was primarily driven by strong global gains in CAG Diagnostics' recurring revenues.
- 01/31/2020
|
Earnings Preview: Idexx Laboratories (IDXX) Q4 Earnings Expected to Decline
- Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- 01/24/2020
|
What's in Store for IDEXX Laboratories' (IDXX) Q4 Earnings?
- IDEXX's (IDXX) is likely to report strong earnings for Q4, courtesy of a global surge in CAG Diagnostic revenues.
- 01/24/2020
|
The No-Brainer Industry You Should Be Investing In
- Recession or not, spending in this industry increases every single year.
- 01/24/2020
|
10 Recession-Resistant Services Stocks to Buy
- Seemingly every day, the fundamentals surrounding the U.S. economy seem to deteriorate.
- 01/22/2020
|
IDEXX Launches Cytology Service to Upgrade Veterinary Care
- IDEXX (IDXX) upgrades veterinary care experience by launching a rapid digital cytology service, thus enabling the provision of faster results.
- 01/20/2020
|
S&P 500 Up 1000 Points in a Month: 10 Stocks Boosted the ETF
- The S&P 500 touched the 3,300 mark on Jan 16, having added 1000 points in less than a month. Which stocks led to the ETF rally.
- 01/17/2020
|
Why IDEXX Laboratories Stock Dropped 12% in November
- Investors needed to see more growth to justify the high valuation on the stock.
- 12/04/2019
|
3 Big Stock Charts for Tuesday: Costco, IDEXX Laboratories, and Ulta Beauty
- Tuesday's big stock charts look at 3 names that could reverse if market strength continues.
The post 3 Big Stock Charts for Tuesday: Costco, IDEXX Laboratories, and Ulta Beauty appeared first on InvestorPlace.
- 11/26/2019
|
You Love Your Dog More Than Humans -- And This Company's Reaping the Benefits
- IDEXX Laboratories is salivating at a $33 billion global addressable market opportunity.
- 11/21/2019
|
Top-Ranked Nasdaq-100 ETF at New High: 5 Best Stocks
- Likelihood of a soon-to-be-signed U.S.-China trade deal, upbeat holiday season sales expectations and decent earnings have led the Nasdaq-100 ETF to a new high.
- 11/13/2019
|
We Love Our Pets, and IDEXX Knows It
- How the diagnostics company could be poised to profit from the companion animal industry.
- 11/12/2019
|
IDEXX Laboratories, Inc.'s (IDXX) CEO Jay Mazelsky on Q3 2019 Results - Earnings Call Transcript
- IDEXX Laboratories, Inc.'s (IDXX) CEO Jay Mazelsky on Q3 2019 Results - Earnings Call Transcript
- 10/31/2019
|
IDEXX (IDXX) Tops Q3 Earnings Estimates, Lowers EPS View
- IDEXX (IDXX) impresses investors with solid third-quarter 2019 results on robust performance across all business segments.
- 10/31/2019
|
13 Stocks With The Highest Returns On Equity
- Return on equity is one of the most popular ways for investors to assess the efficiency of a business before they buy a stock.
- 10/31/2019
|
Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More
- Earnings and revenues for the Medical Instruments sector in the third quarter are likely to have declined sequentially. Read to know how a few companies from the sector might have fared in the period.
- 10/30/2019
|
What's in Store for IDEXX Laboratories' (IDXX) Q3 Earnings?
- Growth in Rapid Assays and Veterinary Software revenues is expected to get reflected in IDEXX's (IDXX) third-quarter results.
- 10/22/2019
|
Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now
- Investors continue to be optimistic about IDEXX's (IDXX) performance.
- 10/16/2019
|
IDEXX's Kidney Function Test Included in IRIS Staging Views
- IDEXX (IDXX) is upbeat about the inclusion and approval of the SDMA-based renal care staging guidelines.
- 10/07/2019
|
3 Recession-Ready Stocks - to Buy Right Now
- If you're looking for conservative stocks to cushion your portfolio against a downturn, look to companies whose offerings are hard to do without.
- 10/04/2019
|
Two Leading Medical Stocks To Know As They Approach Buy Points
- Shares of medical stocks Idexx Laboratories and Masimo approached breakouts Friday as Wall Street enjoyed a third day of gains. Both stocks are now in the process of forming flat bases.
- 09/06/2019
|
Idexx (IDXX) Up 8% Since Last Earnings Report: Can It Continue?
- Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
- 08/31/2019
|
Here's Why You Should Hold Onto IDEXX (IDXX) Stock for Now
- Investor confidence continues to be high on IDEXX Laboratories' (IDXX) prospects.
- 08/20/2019
|
Idexx Laboratories Inc (IDXX) Interim President & CEO Jay Mazelsky Sold $2.6 million of Shares
- Interim President & CEO of Idexx Laboratories Inc (30-Year Financial, Insider Trades) Jay Mazelsky (insider trades) sold 10,000 shares of IDXX on 08/05/2019 at an average price of $258.4 a share.
- 08/07/2019
|
IDEXX Labs Fetches Double-Digit Profit Growth
- The animal diagnostic company continues to turn single-digit revenue growth into big gains on the bottom line.
- 08/03/2019
|
IDEXX Laboratories' (IDXX) Management on Q2 2019 Results - Earnings Call Transcript
- IDEXX Laboratories' (IDXX) Management on Q2 2019 Results - Earnings Call Transcript
- 08/01/2019
|
IDEXX (IDXX) Beats Q2 Earnings Estimates, Lifts EPS Guidance
- IDEXX's (IDXX) top line in the second quarter gains from strong sales at the CAG business.
- 08/01/2019
|
Idexx Laboratories (IDXX) Q2 Earnings Surpass Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 4.38% and -1.25%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
- 08/01/2019
|
Can IDEXX's (IDXX) International Growth Drive Q2 Earnings?
- In the United States, IDEXX (IDXX) witnesses a strong uptrend in CAG Diagnostic recurring revenues.
- 07/26/2019
|
Why the Earnings Surprise Streak Could Continue for Idexx (IDXX)
- Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- 07/23/2019
|
2 Stocks to Play the Pet Care Trend
- With consumers spending as much as $72 billion on their pets in 2018, here are 2 companies that could benefit most from our love of animals.
- 06/24/2019
|
IDEXX (IDXX) Gains Traction From Solid CAG, Global Strength
- IDEXX (IDXX) consistently benefits from strong organic growth, driven by robust sales at the CAG business, fueled by a firm global Catalyst adoption.
- 06/21/2019
|
Why Is Idexx (IDXX) Up 3% Since Last Earnings Report?
- Idexx (IDXX) reported earnings 30 days ago. What's next for the stock?
- 05/31/2019
|
Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now
- IDEXX (IDXX) registers strong revenue growth on the back of CAG Diagnostics.
- 05/29/2019
|
Idexx Labs CEO: Millennials and Pet Care | Mad Money | CNBC
- Idexx Laboratories CEO Jonathan Ayers chats with Jim Cramer about growing demand for preventative care for dogs and cats, and explains growth prospects for the veterinary diagnostics company.
- 05/23/2019
|
Moving Average Crossover Alert: IDEXX Laboratories
- IDEXX Laboratories is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
- 05/06/2019
|
Rising Margins Allow IDEXX Laboratories to Boost Guidance
- Expense control is helping the animal diagnostic company drive double-digit profit growth.
- 05/01/2019
|
IDEXX Laboratories' (IDXX) CEO Jon Ayers on Q1 2019 Results - Earnings Call Transcript
- IDEXX Laboratories' (IDXX) CEO Jon Ayers on Q1 2019 Results - Earnings Call Transcript
- 05/01/2019
|
Idexx Laboratories (IDXX) Beats Q1 Earnings and Revenue Estimates
- Idexx (IDXX) delivered earnings and revenue surprises of 12.50% and 0.83%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
- 05/01/2019
|
IDEXX (IDXX) Q1 Earnings Top Estimates, EPS Guidance Up
- Strong sales at the CAG business favor IDEXX's (IDXX) top line in Q1.
- 05/01/2019
|
Can Steady CAG Growth Drive IDEXX's (IDXX) Q1 Earnings?
- Idexx (IDXX) is expected to continue reporting solid revenue growth on robust CAG performance.
- 04/30/2019
|
Idexx Laboratories CEO: Giving Pets a ‘Voice' | Mad Money | CNBC
- It's the dog days of summer, but Jim Cramer's got one red-hot stock that may be worth owning. He sits down with the CEO of Idexx Labs to see if owning its stock could have you barking up the right tree. » Subscribe to CNBC:
- 08/08/2018
|
